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ABSTRACT
A monoclonal antibody (MAb)-based western blot analysis (WB) was developed 
for detection o f a 26-28 kD coproantigen in Fasciola. hepatica infected cattle. Using WB 
the coproantigen was detected in feces from experimentally infected calves with 22 flukes 
or more. Using the biotin-streptavidin modification of WB, antigen was detected in the 
feces from experimentally-infected calves with 10 flukes or more as early as 6 weeks post­
infection. The MAbs did not react with the ES of Paramphistomum sp. or Moniezia sp, 
but showed slight cross-reactivity with ES from F. gigantica, and there was moderate 
cross-reactivity with Fascioloides magna ES.
Differential staining o f purified 26-28 kD coproantigen on SDS-PAGE, under 
reducing and non-reducing conditions, indicated that the coproantigen was a monomeric, 
highly glycosylated glycoprotein. Alkaline treatment of the purified coproantigen resulted 
in an 8 KD protein core which still contains the epitope recognized by the MAbs. No 
protease activity was associated with the 26-28 kD coproantigen. The coproantigen was 
cleaved by trypsin without altering the reactive epitope, but was resistant to pepsin 
treatment. The coproantigen was stable under several different storage conditions. Indirect 
immunofluorescence on tissue sections of adult flukes indicated that coproantigen was 
present on gut cells and tegument.
A capture enzyme-linked immunosorbent assay (ELISA) was developed for the 
detection of the 26-28 kD coproantigen. Monoclonal antibody M2 DS/DSF10 was used
to capture the antigen from the feces and hyper-immune rabbit ant-26-28 kD glycoprotein 
followed by peroxidase labeled goat anti-rabbit immunoglobulin was used for detection. 
The assay was able to detect down to 300 pg coproantigen /ml. Feces from 27 
experimentally-infected calves with known numbers o f flukes were used to evaluate the 
test. Pre-infection feces from the same animals were used as negative controls. 
Coproantigen was detected in feces of calves with more than 10 flukes.
In conclusion, both the coproantigen capture ELISA and WB were both more 
sensitive than microscopic examination for the diagnosis of Fasciola infection and both 
could detect pre-patent infections. Moreover, the ELISA for the detection o f coproantigen 




RATIONAL FOR THE PRESENT STUDY:
Fasciola hepatica is a cause of major economic losses to the cow-calf, 
stocker and feedlot phases of the United States cattle industry. Moderate to heavy F. 
hepatica infections (over 40 flukes) result in production losses in cow-calf operations in 
the major enzootic areas of the Southeastern and Northwestern US and in stocker 
operations in the Midwest and elsewhere that receive calves from fluke zones. If  the flukes 
are not removed by treatment or partial self-cure, performance losses are passed on to 
feedlot operators, along with liver condemnation losses.
Fasciola hepatica occurs in the bile ducts of ruminants, other animals and man. 
Infection with Fasciola occurs by ingestion of the encysted metacercaria on the grass. 
Following excystation in the duodenum of the host, the immature flukes penetrate the 
intestine, wander in the abdominal cavity for 4-6 days and then penetrate the liver capsule. 
Immature flukes migrate in the liver parenchyma for 5-6 weeks, then enter the bile duct 
where they mature and start egg shedding approximately 8 weeks after infection. The eggs 
enter the intestine with the bile and leave the host in the feces. In appropriate enviromental 
conditions eggs develop on pasture in water and hatch in about 10-12 days producing the 
miracidia. Further development requires a snail of the Lymnaeid group. The miracidium 
actively penetrates the snail where it develops in the hepatopancreas sequentially into
sporocyst, rediae and cercariae. The cercariae leave the snail 5 to 7 weeks after infection. 
Cercariae are attracted to light and green color characterestic of the plants at the margin of 
habitats. Cercariae adhere to the vegetation, lose their tails and form a cyst wall that protect 
cercaria until ingestion by the final host.
Definitive diagnosis of fasciolosis is usually achieved by traditional parasitologic 
methods that depend on identifying eggs in the feces. However, F. hepatica does not 
mature and shed eggs until two month after infection, and in many instances significant 
damage has already occurred in the host before a clear diagnosis is possible. Also F. 
hepatica eggs may be confused with eggs from other trematode parasites such as 
Cotylophoron cotylophorum and Paramphistomum spp. Moreover standard fecal 
sedimentation procedures for quantitating fecal egg counts are time consuming (15-30 min 
per sample) and prone to technical error. Examinations must be done on at least 10 animals 
per herd or purchase lot due to parasite overdispersion, the normal biological variation of 
infection intensity that occurs between individuals in a population, and because stocker- 
feedlot calves are typically grouped from several sources that may or may not be from fluke 
areas.
An immunodiagnostic test may overcome many of these difficulties and provide 
more accurate, sensitive and rapid means for the diagnosis for fasciolosis. While 
serodiagnostic tests rely on the detection of antibodies in the infected host, these tests only 
indicate exposure to the parasite and may not be related to current infection burdens, 
especially after treatment. Tests based on detection of circulating parasite antigens indicate
active infection; however, these circulating antigens tends to form immunocomplexes 
resulting in lower sensitivity o f the assay. Moreover, these antigens may not be available 
in the circulation after the fluke is established in the bile duct. Detection o f parasite- 
specific antigens in the feces has been successfully used for diagnosis of several parasites. 
Coproantigen diagnosis has the advantage o f detecting only active infections. In addition, 
coproantigen should be detectable as long as the fluke is present in the bile duct and 
therefore can be used to detect both acute and chronic infection. The goal o f this work was 
to develop a sensitive, rapid diagnostic test to detect coproantigen in the feces o f infected 
cattle.
OBJECTIVES:
The overall objective o f this study was to develop a rapid, sensitive and specific 
procedure for detection o f mature and pre-patent F. hepatica infection by detection of 
coproantigen in infected cattle. In previous work in our laboratory, a 26-28 kD diagnostic 
coproantigen was detected by WB using bovine and rabbit serum and four monoclonal 
antibodies had been developed against this band. The specific objectives o f the current 
work are:
1. To confirm the specificity o f the 4 Mabs for the 26-28 kD coproantigen 
present in the feces of cattle infected with F. hepatica using WB and to
determine the sensitivity of the Mabs based WB for diagnosis o f F. hepatica 
infection.
2. To identify the biochemical nature o f the 26-28 kD coproantigen and 
determine the stability of the antigen under different conditions.
3. To determine the location o f the 26-28 kD coproantigen on the bile duct stages 
o f F. hepatica.
4. To develop an ELISA for diagnosis of F. hepatica using MAb and polyclonal 
antibodies specific for the 26-28 kD coproantigen in the feces o f cattle
LITERATURE REVIEW:
Definitive diagnosis of fasciolosis in is usually achieved by traditional parasitologic 
methods that depend on identification of eggs in the feces. These procedures are time 
consuming and inefficient indicators of infections since egg counts are variable, and in 
cattle are commonly less than 5 eggs per gram of feces, even in heavily infected herds. 
Moreover, herd egg counts peak and wane depending on seasonal transmission (Malone 
and Craig, 1990). Duwel and Reisenleiter (1990) monitored egg shedding in bulls 
experimentally infected with different numbers of F. hepatica metacercaria Fasciola eggs 
fluctuated within individual animals and within one infection group, and the distribution 
o f Fasciola eggs in the feces was irregular within a single day and over several days in all 
animals. F. hepatica matures and lays eggs approximately 8 weeks after infection. Acute 
symptoms occur early in the infection, due to the migration of the fluke in the liver;
therefore, eggs are not in the feces during acute fasciolosis. Moreover, in many cases, F. 
hepatica eggs may be confused with eggs of other trematode parasites such as 
Cotylophoron sp. and Paramphistomum spp. An immunodiagnostic test may overcome 
many o f these difficulties in the diagnosis o f fasciolosis and provide more accurate, 
sensitive and rapid means of diagnosis.
Serological diagnosis:
As early as 1950, Oliver-Gonzalez et al., developed an intradermal test to 
differentiate between F. hepatica infected and non-infected cattle. This test and similar 
tests (Maekawa et al., 1954; Maekawa and Kushibi, 1965; Pautrizel et al., 1962) 
demonstrated cross-reactivity in cattle with tuberculosis and in patients with 
schistosomiasis (Rifaat and Abdel-Aal, 1968).
Early approaches in the serodiagnosis of fasciolosis included complement fixation 
test (CF) and indirect fluorescence assay (IFA). The CF test proved to be unreliable 
(Platzer, 1970). IFA using F. hepatica miracidia was used to diagnose infections in sheep 
and man (Faraga de Acevedo and Rombert, 1965). This IFA had a sensitivity o f 74-80%, 
but some cross-reactivity was seen with the sera o f human patients with Schistosoma 
haematobium. Other reports used sections from the adult flukes in IFA for diagnosis of 
F. hepatica ( Coudert et al., 1967; Deelder, 1973). Hanna and Jura (1977) used freshly 
excysted F.gigantica as an antigen for an IFA test to monitor experimentally infected 
animals. Antibodies were detected 2-6 weeks post-infection and diminished gradually to
the pre-infection levels by 22 weeks post-infection, which suggested there were difference 
in antigenicity o f juvenile and mature flukes.
To develop more specific immunological tests for diagnosis o f F.hepatica, a 
number of authors intiated investigations directed at increasing knowledge on the detected 
antigens. Numerous antigens have been identified in the tegument of F. hepatica. Hillyer 
(1980) isolated F. hepatica tegument antigens and used them for serodiagnosis of 
experimentally infected rabbits using immunodiffusion against the rabbit serum. He also 
found that the tegument contained antigens that protected mice from challenge infection 
with Schistosoma mansoni.
The tegument of the F. hepatica consists of two main layers; the outer zone, or the 
distal cytoplasm, where the spines are embedded, and the proximal cytoplasm which 
contain the tegumental cells. The distal cytoplasm is coated by the glycocalyx which is 
sloughed continuously. The proximal cytoplasm cells are responsible for maintaining the 
glycocalyx. Proximal and distal cytoplasm are connected by tubules underlying these 
tegumental cells and the translocation of the content of these cells to the distal cytoplasm 
takes place through these connecting tubules (Bennett and Threadgold, 1973, Bennett and 
Threadgold, 1975). Hanna (1980a) reported that in the newly excysted juvenile these 
tegumental cells are unique and he designated them as TO cells. During migration to the 
liver the TO cells metamorphose into T1 cells which, although morphologically distinct, are 
produced in the same perikarya and may possess similar antigenicity and function. The T1 
cells secret T1 granules. Upon entering the bile duct as immature flukes, T2 cells, which
arise from different perikarya, start to appear; and for a transitional period the glycocalyx 
is formed by both the T1 and T2 granules, followed by a decrease in the number o f T1 cells 
(Hanna 1980a). Hanna and Trudgett (1983) raised 6 MAbs against the tegumental antigen 
present in T1 granules and the glycocalyx of the flukes. These MAbs were found to bind 
the same T1 epitope. They found that T1 type antigen consisted o f a polypeptide with a 
MW of 50 kD, possibly linked to smaller entities with a MW of 25- 40kD.
Santiago de Weil et al. (1984) isolated F. hepatica antigens which induce antibody 
formation in acute fasciolosis. These antigens, when fractionated through Sephacryl S-200 
column, resulted in three major peaks. The best serologic antigens were found in peak 2 
(MW of 14 kD-43 kD). This peak contained F. hepatica genus specific antigens that did 
not cross-react with either Schistosoma mansoni antigens or with bovine serum albumin. 
By WB, using rabbit antiserum raised against peak 2, Santiago de Weil et al. (1986a) found 
that the antigen consisted of one main polypeptide of MW of 12 kD, and 6 additional 
peptides in the 26-62 kD range.
Santiago and Hillyer (1986b) identified a 23 - 28 kD polypeptide complex o f F. 
hepatica ES, which induced an antibody response in both acute and chronic fasciolosis. 
Hillyer and Soler de Galanes (1988) identified an F.hepatica antigen o f 17 kD which was 
recognized by the serum of humans, calves, sheep and rabbits with fasciolosis, and did not 
cross-react with sera from individuals infected with Schistosoma mansoni or Trichinella 
spiralis. They suggested that the 17 kD antigen might be an excellent candidate for 
immunodiagnosis o f acute and chronic fasciolosis.
Enzyme linked immunosorbent assay (ELISA) has been used by a number of 
investigators in efforts to develop tests for serodiagnosis o f fasciolosis. Burden and 
Hammet (1978) used the ELISA to detect bovine fasciolosis using crude F. hepatica worm 
extract. Hillyer (1978) adapted the ELISA for serodiagnosis o f F. hepatica in rats using 
partially purified crude antigen, and reported that the antibody titer rose by the second week 
of infection in rats, reached its highest level 4 weeks post-infection and remained high 
through 12 weeks post-infection. In a similar study in rabbits, Hillyer and Santiago de Wiel 
(1979) found that the antibody titer was the highest by the fourth week post-infection and 
remained high through 28 weeks post-infection. Farrell et al. (1981) detected antibodies 
to F. hepatica in cattle as early as 4 weeks post-infection using freshly collected fluke 
extracts. Zimmerman et al. (1982), used an ELISA and fresh fluke antigen to detect 
antibodies to bovine Fasciola infection as early as 2 weeks after infection. Oldham (1983) 
detected anti F. hepatica antibodies 3 weeks after infection using a semi-purified high MW 
antigen. Hillyer et al. (1985) monitored F. hepatica experimentally infected calves by gel 
diffusion, counterelectrophoresis (CEP) and ELISA using crude antigen; serological 
diagnosis was positive as early as 2-4 weeks of infection by gel diffusion, by 4 weeks by 
CEP, and by 6-8 weeks by ELISA, whereas parasitologic diagnosis via the detection of 
flukes eggs in the feces was possible only after 8-10 weeks. Zimmerman et al. (1985) 
developed a test for ovine fasciolosis using dot ELISA that successfully detected the 
antibodies 4 weeks after infection. Wyckoff and Bradley (1986) developed an ELISA for 
quantitative diagnosis of bovine fasciolosis. They detected the antibodies as early as 2
weeks post-infection and also found a correlation between the antibody level and the fluke 
burden. Similar results were obtained for sheep and cattle by Santiago and Hillyer (1988). 
Using ELISA, Espino et al. (1987) used ES of F. hepatica to detect anti-F. hepatica 
antibodies in sera from human patients with fasciolosis without cross-reactivity in serum 
from patients with schistosomiasis, clonorchiasis, ascaris or hookworms. Carlos et al. 
(1988) evaluated an immunodiagnostic antigen in the ES product o f F. hepatica after 
fractionation by gel filtration, and found that a component with a MW o f 150-160 kD was 
very reactive with sera of rabbits with early fasciolosis. They also found that serum from 
both acute and chronic fasciolosis recognized a prominent 25-30 kD polypeptides 
component. These polypeptides were also recognized by sera from infected sheep and 
cattle. Fagbemi and Guobadia (1995) used a 28 kD cysteine protease of F. gigantica adult 
worm as antigen for immunodiagnosis of fasciolosis in cattle, sheep and goats. Several 
other ELISA, dot ELISA and FAST ELISA tests have been developed by modifications 
of the above tests and used for diagnosis of fasciolosis in human and animals (Sinclair and 
Wassail (1988); Shaheen et al. (1989); Hillyer and Soler de Galanes (1991); Hillyer et al. 
(1992); Yang and Lan (1992); Richard (1995).
Another serological method that has been used successfully for early diagnosis of 
fasciolosis is the detection o f specific anti-f2 antigen using hemagglutination tests. F2 
antigen has a tegumental origin and has been shown to be specific and immunogenic 
(Hillyer, 1980; Santiago de Weil et al., 1984). Levieux et al. (1992a) used this assay to 
detect anti-Fasciola antibodies in experimental infected calves as early as 2-4 weeks post­
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infection and the titer persisted at high levels during the 28 week experimental period. This 
test was evaluated with the respect to its potential use in the diagnosis of caprine fasciolosis 
by Levieux et al. (1994b) who detected the f2 specific antibodies at 2-3 weeks post­
infection, with the maximum titer at 9 weeks after infection, after which the antibody titer 
declined.
Circulating antigen:
Although the use of ELISA for detection o f antibodies in the infected host is a 
valuable diagnostic method, especially in detection of early infection, the persistence o f 
antibodies for a long period after treatment makes differentiation between the exposure to 
the parasite and active infection difficult (Hillyer, 1993). Recent studies have focused on 
the immunodiagnosis of F. hepatica by detection of Fasciola circulating antigens. Antigen 
detection has the advantage over antibody-based tests in that the antigenemia implies 
current infection. Sampaio- Silva et al. (1981) detected immunocomplexes in sera o f 
Fasciola infected patients using a Clq binding assay and found that only 36% of the 
previously confirmed positive samples were positive by the test. Using a two-site ELISA 
Langley and Hillyer (1989a) detected circulating parasite antigen in murine fasciolosis as 
early as 1 week post-infection with the maximum detection level at 3 weeks after infection. 
Langley and Hillyer (1989b) detected circulating immunocomplexes in sera o f 5 F. 
hepatica infected calves with fluke burdens ranging from 27 to 70 flukes. Circulating 
immunocomplexes were detected 6-8 weeks after infection, returned to approximately pre­
infection levels and then rose slightly thereafter. With capture ELISA, utilizing a
monoclonal antibody to capture the circulating F. hepatica antigens in human sera, and 
peroxidase conjugated human polyclonal antibody to identify these circulating antigens, 
Espino et al. (1987) detected antigen concentration as low as 10 ng/ml; there was no cross­
reactivity with other parasite antigens. Rodrigue-Perez and Hillyer (1995) used rabbit anti- 
F. hepatica ES and sheep anti-F. hepatica ES in a capture ELISA to detect circulating 
antigen in experimentally infected sheep. They were able to detect antigen as early as 4-6 
week post-infection with maximal detection at 8 weeks post-infection.
Coproantigen:
While serum antigen detection methods have advantages over serum antibodies 
detection methodes, the use of serum samples to detect parasite antigen has two 
disadvantages: first, circulating antigen tends to form immunocomplexes with host 
antibody which deceases the potential rate of detection (Langley and Hillyer, 1989b) and 
Second, The collection of serum samples require animal handling and are often 
inconvenient to obtain, especially for herd evaluations. Diagnosis of parasitic infection by 
detection o f parasite specific antigen in the feces was first reported in 1962, by Bobos and 
Nemith, who used hyperimmune rabbit serum raised against hydatid cyst fluid to detect 
Echinococcus granulosus coproantigen using the double gel diffusion. Antigen was 
present before the infection became patent, but the test cross-reacted with samples from 
taenia-infected individuals.
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Among protozoan parasites, Craft and Nelson (1982), detected Giardia antigen in 
human feces by counterimmunoelectrophoresis. ELISA was later used to detect 
coproantigen in human Giardia infections. Using anti-trophozoite hyperimmune goat 
serum to capture the antigen from feces and anti-trophozoite hyperimmune rabbit serum 
to detect the bound antigen, Ungar et al. (1984) developed an ELISA for detection of 
Giardia lamblia in human feces. The assay detected the antigen in 92% of patients with 
giardiasis. Patients who received treatment became negative by the test. The usefulness 
o f ELISA for detection o f the antigen in the feces was determined in experimentally 
infected humans by Nash et al. (1987) who concluded that the test is at least as sensitive 
as microscopic examination for diagnosis of Giardia infections and that the ELISA is 
easier to perform. In a parallel study, hyperimmune rabbit anti-G. lamblia cyst serum was 
used to detect G. lamblia coproantigen (Rosoff and Stibbs, 1986) by CEP and WB. A 
diagnostic G. lamblia coproantigen was identified that had a MW of 65 kD (GSA 65). The 
antigen was specific for G. lamblia. Stibbs et al. (1988) developed a capture ELISA test 
for detection o f GSA 65 antigen in the feces o f infected patients. They found the test 
more sensitive than the trophozoite- derived antigen assay. Rosoff et al.(1989) evaluated 
a commercially available ELISA for detection of GSA 65 in a clinical trial and found that 
the ELISA performed well on fecal samples treated with 10% natural formalin, sodium 
acetate-formalin fixative, and Cary-Blair transport medium. Vinayak et al. (1991) 
developed a dot ELISA for detection o f G.lamblia antigen in stool eluates using clinical 
cases o f giardiasis. They concluded that their test was easy, rapid, sensitive and specific
and that it could detect the subclinical cases that were negative by microscopic 
examination. Ungar (1990) developed a capture ELISA for detection o f Cryptosporidium 
antigens in human fecal
specimens using specifically produced goat and rabbit anti-Cryptosporidium antigens. 
Cryptosporidium detection ELISA kits are now commercially available and have been 
evaluated (Siddon et al., 1992; Newman et al., 1993). El-Shewy et al. (1994) identified 
Cryptosporidium parvum  coproantigens of 18 and 20 kD in stool eluates o f calves and 
humans infected with Cryptosporidium species. Both of these bands were recognized by 
monospecific antibodies raised against the 20 kD antigen which reacted with C. parvum  
trophozoites by IFA. The antigens remained detectable in fecal samples stored with 
commonly used preservatives and at various temperatures. For amoebiasis, several assays 
involving both monoclonal and polyclonal antibodies had been developed (Ungar et al., 
1985; Jain et al., 1990; Agarwal et al., 1991; Vinayak et al., 1993). In 1994, Haque et al., 
developed a capture ELISA for detection o f pathogenic Entamoeba histolytica coproantigen 
using purified rabbit polyclonal antibody against the galactose adhesion molecule to trap 
the antigen, and a MAb directed against a pathogen-specific epitope o f that molecule for 
detection. They found their test had a specificity of 97% and sensitivity o f 100%. Sharma 
et al. (1994) developed an ELISA to distinguish the pathogenic E. histolytica from the non- 
pathogenic E. dispare using MAbs directed against cross-reactive and E. histolytica- 
specific epitopes o f galactose adhesion molecule. Gonzalez-Ruiz et al. (1994) used an
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invasive E. histolytica strain-specific monoclonal antibody in a capture ELISA and 
detected the fecal antigen with a sensitivity o f 87% and specificity o f 100%
Coproantigen detection tests have been developed for diagnosis o f several cestodes. 
Allan et al. (1989) developed a capture ELISA for detection o f Hymenolepis diminuta 
coproantigen in fecal supernatant of infected rats. They found that fecal antigen levels 
could be detected one week after infection with the maximum antigen detectable at 3 
weeks. Following drug treatment of the infected rats, there was an initial steep rise in fecal 
antigen levels, followed by decline to the pre-infection level. Deplazes et al. (1990) used 
affinity-purified polyclonal antibodies raised against ES antigens o f adult Taenia 
hydatigena to detect antigen in fecal samples o f infected dogs. The antigen was first 
detected at 18 days after infection and showed no cross-reactivity with other cestodes or 
nematodes. Allan, et al. (1990) developed a capture ELISA for detection o f coproantigen 
from Taenia solium  and Taenia saginata infected hosts; although there was no cross­
reactivity between the two species when fecal samples from experimentally infected 
hamsters were used, cross-reactivity was detected when human fecal samples were used. 
Patients previously diagnosed as positive became negative 6 days post-treatment. Deplazes 
et al. (1990) used affinity-purified polyclonal antibodies raised against ES antigens o f adult 
T. saginata to detect coproantigen and found the antigen in 85% of the fecal sample of 
infected patients, whereas eggs were detected in only 62% o f the cases. Maass et al. (1992) 
isolated the immunodiagnostic coproantigen from fecal samples o f known T. solium 
carriers by several chromatographic purification methods. The 60 kD protein, a major
antigenic component excreted with the feces, was shown to react by WB with polyclonal 
anti-71, solium IgG. Allan et al. (1993) used antibodies raised against adult T. solium in 
immunosuppressed, experimentally infected hamsters to develop a dipstick dot ELISA for 
the detection o f Taenia coproantigen in people. The test showed 99% specificity. Some 
of these tests were applied in field studies carried out in China and Guatemala that revealed 
a high specificity (Allan et al.1992). In the same study, antiserum against T. pisiformis 
antigen extract was used to detect the coproantigen in T. pisiforms o f experimentally 
infected dogs. They found that the antigen was present in the feces before patency and 
antigen levels were independent of T. pisiformis egg output.
Following the pioneering work of Babos and Nemeth (1962), coproantigen o f E. 
granulosus was later detected by ELISA in E. granulosus infected dogs using rabbit 
hyperimmune serum against saline extracts of the non-gravid proglottids o f E. granulosus 
(Allan et al., 1992). The test had 87.5% sensitivity and 95% specificity when tested against 
samples from dogs naturally infected with Echinococcus or Taenia. Walters and Craig 
(1992) used this test in the field and found it to be convenient and highly sensitive. Using 
protein-A-purified polyclonal antibodies against ES of Echinococcus, Deplazes et al. 
(1992) developed an ELISA for detection of Echinococcus coproantigen in fecal samples 
of dogs, dingoes and foxes infected with either E. granulosus or E. multilocularis . They 
were able to detect E. granulosus antigen 10-20 days post-infection and E. multilocularis 
antigen 5 days post-infection, but the test was not sensitive enough for detection o f low 
level infections (< 70 worms). Baronet et al. (1994) used the ELISA protocol described
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by Allan et al. (1992) to detect E. granulosus coproantigen in a field study using rabbit 
hyperimmune serum specific for adult E. granulosus (proglottids) somatic antigen. The 
test had a sensitivity of 88% for burden of >15 worms. Two ELISA immunodiagnostic 
tests based on genus-specific coproantigen detection or serum antibody detection were 
compared with arecoline purgation for detection o f Echinococcus in naturally infected dogs 
in Uruguay (Craig et al., 1995). The coproantigen ELISA was more sensitive than the 
ELISA for anti- Echinococcus serum IgG. Moreover, coproantigen reactivity was 
positively correlated to purge worm count, but there was no correlation o f antibody levels 
with worm count.
For coproantigen diagnosis of the intestinal nematodes, Ellis et al. (1993) developed 
an antigen capture ELISA that could identify Haemonchus contortus antigen in feces from 
naturally infected sheep with moderate parasite burdens. The ELISA used rabbit or sheep 
polyclonal antibody to capture the coproantigen. The captured antigen was detected by a 
mouse MAb specific for a cuticle surface antigen of H. contortus. Characterization of the 
reacting antigen using the MAb indicated that the antigen was a collagenase and protease 
resistant surface protein of H. contortus with a MW of 122, 65, and 49 kD on SDS-PAGE 
under reducing conditions. Nageswaran et al. (1994) investigated the potential for 
coproantigen detection for diagnosis of strongyloidiasis in rats experimentally infected with 
Strongyloides ratti. A capture ELISA was developed using affinity-purified polyclonal 
antibodies raised in rabbits against adult and filariform larvae somatic antigens. Using anti- 
larval antibodies they detected the coproantigen 5 days after infection and coincided with
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the appearance o f the eggs and larvae in the feces. Peak antigen level was detected 9 days 
after infection and remained relatively high until day 25 post-infection. The same results 
were obtained when anti-adult somatic antigen capture ELISA was used, but coproantigen 
was detectable until day 46, when the experiment was terminated.
The first report o f coproantigen diagnosis of flukes was for Opisthorchis felineus 
(Teplukhin et al., 1986). Using passive hemagglutination and antibody neutralization they 
detected the antigen in the feces of Opisthorchis-infected human patients. Sirisinha et al. 
(1991) later reported a potentially useful MAb-based ELISA for the detection of 
coproantigen from a small number of patients with opisthorchosis. The method was based 
on the detection of a 89 kD O. viverrini metabolic antigen present in the feces. The assay 
was estimated to be sensitive enough to detect antigen produced by a single mature fluke. 
Sirisinha et al. (1995) later evaluated this MAb-ELISA based assay for the diagnosis o f O. 
viverrini infection and showed that the ELISA was sufficiently sensitive and specific for 
the diagnosis o f O. viverrini.
Youssef et al. (1991) reported a counterimmunoelectrophoresis method that used 
hyperimmune serum from rabbits immunized with partially purified Fasciola gigantica 
antigen to detect coproantigen in saline extract of human patients' stools. The test was 
specific and detected the antigen 3-4 weeks before microscopic detection o f the eggs. El- 
Bahi et al. (1992) identified a 26 kD diagnostic F. hepatica antigen in the bile, intestinal 
content and feces o f F. hepatica infected cattle by WB using hyperimmune rabbit 
serumraised against fresh fluke antigen. Four MAbs were developed against the 26-28 kD
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coproantigen as part o f their studies and these antibodies were used for the research 
reported in this dissertation. Espino and Finlay (1994) laterf developed a capture ELISA 
for detection o f a fecal antigen in human fasciolosis. That test utilized a MAb to capture 
the antigen and rabbit anti-ES polyclonal antibody to detect the antigen. They reported 
that the test was specific and that the antigen was not found in the feces o f the treated 
persons.
CHAPTER II
DETECTION OF A FASCIOLA HEPATICA 26-28 kD DIAGNOSTIC 
COPROANTIGEN BY WESTERN BLOT ANALYSIS USING 
MONOCLONAL ANTIBODIES
INTRODUCTION:
Fasciola hepatica is one o f the most economically important trematode parasites 
o f domestic animals. Definitive diagnosis o f fascioliasis is usually achieved by the 
identification of eggs in the feces; However, F. hepatica does not mature and shed eggs 
until two month after infection, and in many instances significant damage has occurred to 
the host before a clear diagnosis is possible (Hillyer, 1986). Serodiagnostic tests for the 
detection o f antibodies in infected animals have been developed ( Hillyer et al., 1985; 
Zimmerman el al., 1985; Welch et al., 1987; and Hillyer and Soler de Galanes, 1991) 
These tests can identify animals that are infected before mature worms are present, but 
antibody levels may not be related to current infection burdens, especially after treatment. 
Detection o f circulating parasite antigen indicates active infection, however, the collection 
o f serum samples require animal handling which are often inconvenient to obtain, 
especially for herd evaluations. Diagnosis o f parasitic infection by detection o f parasite 
specific antigen in the feces was first reported in 1962, by Bobos and Hemeth, who used 
hyperimmune serum to detect Echinococcus granulosus coproantigen using the double 
diffusion technique. In 1982, Craft and Nelson detected Giardia antigen in human feces
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by counter immunoelectrophoreses. ELISA was later used to detect coproantigen in human 
Giardia infection (Ungar et al., 1984; Green et al. 1985; Rosoff and Stibbs, 1986), and 
Cryptosporidium infection (Ungar, 1990) and ELISA diagnostic tests for both parasites are 
now commercially available. ELISA methods have also been developed for detection of 
coproantigen of cestodes. Using hyperimmune sera, coproantigen has been detected in 
Echinococcus granulosus infected dogs (Allan et al., 1992; Deplazes et al., 1992, 
Deplazes et al., 1994; Walters and Craig, 1992; Craig et al., 1995.), Taenia pisiformis 
infected dogs ( Allan et al.,1992), Hymenolepis diminuta infected rats ( Allan et al., 1989), 
as well as Taenia solium and Taenia saginata infected human (Allan, et al., 1990; Mass 
et al., 1992; Allan et al., 1993). More recently intestinal nematodes have been identified 
using immunodetection of coproantigen. Coproantigen o f Strongyloides ratti in rats 
(Nageswaran et al., 1994) and Haemonchus contortus in sheep (Ellis et al.,1993) have been 
detected.
Coproantigen was used for the detection o f the liver trematode Opisthorchis felineus 
by Teplukhin et al. (1986) using indirect hemagglutination and by Sirisinha et al. (1991) 
using ELISA. Fasciola gigantica coproantigen was detected in human feces using 
counterimmunoelectrophoresis (Youssef et al., 1991). El-Bahi et al. (1992) reported 
detection o f a 26 kD coproantigen from the bile, intestinal content and feces of F. hepatica 
infected cattle using hyperimmune bovine and rabbit serum in western blot analysis, and 
Espino and Finlay (1994) were able to detect the coproantigen in human fasciolosis using 
sandwich ELISA.
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Current procedures for diagnosis of Fasciola infection by fecal egg counts are time 
consuming and prone to technical error, especially for herd evaluations (Malone and 
Zukowski, 1992). Moreover, it is not possible to detect infection before egg shedding and 
mature flukes are present. The objective of the current study was to develop a sensitive and 
specific procedure for detection of mature and pre-patent infections in F. hepatica infected 
cattle. I describe here detection o f coproantigen in cattle using monoclonal antibodies 
(MAbs) in a WB and development o f a test for detection o f low worm numbers and the 
premature infection by detection of coproantigen in cattle. This coproantigen-based test 
offers several advantages over current serologic tests: 1) fecal samples can be collected 
without animal handling; 2) the same test can be used for several host species; 3) only 
current infections are detected and 4) quantitation o f fluke burden may be possible.
MATERIAL AND METHODS: 
Monoclonal antibodies:
Six to eight weeks old female BALB/c were immunized intraperitonially (IP) with 20- 
52 pg/ml F.hepatica ES and boosted, IP, with the 26-28 kD protein blotted on a 
nitrocellulose membrane from a gel loaded with an equivalent amount o f F  hepatica 
(Harlow and Lane, 1988). Fusion of the mouse myeloma cell-line SP2/0 (American Type 
Culture Collection, ATCC, Bethesda, MD) with spleen cells of the immunized mice was 
performed as previously described (St. Groth and Scheidegger, 1980). Hybridoma culture 
supemates were screened for the presence of antibodies against ES and fresh fluke antigen
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(FFA) using ELISA according to the method o f Santiago and Hillyer (1988). Four 
hybridomas producing antibodies, M2DS/DSF10 (F10), M7 D5/G7 (G7), M1CS/E7 (E7) 
and M7D5/A11F7 (F7) were identified and cloned by limiting dilution. Ascites fluid was 
produced from each hybridoma according to the method o f Gallate (1987). These MAbs 
were determined to be of the IgM/ic isotype using the SEA Fisher Biotech Clonotyping 
System II (Fisher Scientific, Pittsburgh, PA). Monoclonal antibodies were purified from 
ascites using ImmunoPure IgM Purification Kit (Pierce Chemical Co, Rockford, IL). 
Protein concentrations were determined by the Bio-Rad Protein Assay (Bio-Rad 
Laboratories Inc., Hercules, CA) according to the manufacturer's instruction. Antibody 
concentrations were adjusted to 1:1.4 mg/ml protein and stored at - 20°C. MAbs were 
biotinylated using ImmunoPure NHS-LC- Biotin ( Pierce Chemical Co, Rockford, IL) 
according to the manufacturer's instructions and stored at 4°C.
Animals:
Yearling cattle were obtained from a fluke free area and were confirmed to be fluke- 
free by using a sieve-sedimentation egg count procedure (Flukefinder, Mosco, ID). Each 
animal was experimentally infected with 500 metacercarae. Fecal samples were collected 
6, 8,11,13 and 14 weeks post-infection for fecal egg counts. Sedimentation and egg count 
were performed as above except that 6 gm of feces were used instead o f 2 gm to increase 
the sensitivity. Fecal samples were stored at 4 °C. Animals were slaughtered 14 weeks 
after infection and the number of flukes recovered from each animal was determined at 
necropsy by the method o f Malone et al. (1982).
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Excretory secretory product (ES):
F. hepatica ES was prepared as described by Santiago and Hillyer (1986). Briefly, 
adult flukes were removed from the bile duct of naturally infected cattle and washed 3 to 
4 times in a 1 hr period at room temperature with 0.01 M phosphate buffered saline, pH 
7.2 (PBS) in order to remove all traces of blood and bile and to allow flukes to regurgitate 
cecal contents. Flukes were then incubated in PBS, at 37°C for 3 hr. After incubation, the 
solution was collected and centrifuged at 5,000 x g. The supernatant was collected and 
concentrated to 1/5 its original volume using Centriprep 10 concentrators (Amicon Inc., 
Beverly, MA). Protein concentration was determined using Bio-Rad Protein Assay 
according to the manufacturer's instructions and the ES was stored at - 20° C .
Fresh fluke antigen (FFA):
Fresh fluke antigen was prepared by the method of Farrell et al. (1981). After 
washing flukes for 3 min in PBS, 1 ml of PBS per gram of parasite was added and flukes 
were ground in a mortar until no visible tissue particles remained. Fluke tissue was then 
homogenized using a Tenbroek tissue grinder to obtain a uniform suspension and stored 
over night at 4°C. The homogenate was then centrifuged at 12,000 x g for 30 min. 
Supernatant was collected and its protein content was determined using Bio-Rad Protein 
Assay. The FFA antigen was stored at - 20°C. Excretory secretory product and FFA of 
Paramphistomum microbothriodes and Moniezia sp. were prepared by the same method. 
Fascioloides magna ES and FFA were provided by Dr. B.E. Stromberg, University of 
Minnesota St Paul, MN.
24
Fecal sample preparation:
Fecal supernatant were prepared for coproantigen immunodetection according to
El-Bahi et al. (1992). Briefly, 5 gm of feces were mixed with an equal amount o f distilled
water and sonicated for 5 min (150 Watt interrupted pulse output at 50% duty cycle using
a Sonifier Cell Disrupter Model W 350). The fecal suspension were centrifuged at 1900
x g for 15 min. The supernatant was dialyzed in 6-8 kD dialysis tubes overnight at 4 °C
against 2 changes of PBS. Fecal supernatant were then concentrated to 1/5 o f the original
volume by absorption against polyvinyl pylorridone 36 kD and stored at -20°C until use.
Sodium dodocyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and Western 
blotting:
Sodium dodocyl sulfate polyacrylamide gel electrophoresis was performed 
by the method of Laemmli (1970). A 4% stacking gel and a 12% separating gel were used. 
Samples were diluted 1:2 in 0.625 M Tris-hydrochloride pH 8.0, 10% (v/v) glycerol, 2.3% 
(w/v) SDS and 5% (v/v) 2 - mercaptoethanol (sample buffer) and boiled at 100°C for 5 
min. Ten pi o f the diluted samples in the sample buffer were applied to SDS-PAGE gel 
at 150 V. Proteins were transferred from polyacrylamide gel to immobilon-P transfer 
membrane (Millipore Corporation, Bedford, MA ) and the blotted protein were analyzed 
by the method of Towbin et al.(1979) . Briefly, membranes were soaked overnight in 
blocking buffer consisting of 0.05M Tris, 0.001M EDTA and 0.15 NaCl pH 7.4 (NET) 
containinglO % non fat dry milk for the indirect assay or 3% fish gelatin in case of 
biotinylated MAbs. Membranes were washed 4 times for 10 min using NET buffer
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containing 0.05% Tween 20, then transferred to 10pg/ml ofMAbsor 1 fag biotinylated 
MAbs in freshly prepared blocking buffer. After a 1 hr incubation with gentle shaking, the 
membrane was washed as before and transferred to a 1:500 dilution o f peroxidase- 
conjugated goat anti-mouse IgG (H&L) (Jackson ImmunoResearch Laboratories, Inc.. 
West Grove PA.) in the blocking buffer for MAbs or to a 1:10,000 dilution peroxidase- 
conjugated streptavidin (Jackson ImmunoResearch Laboratories, Inc, West Grove, PA.) in 
blocking buffer for biotinylated MAbs. After incubation with gentle agitation for 1 hr, 
membranes were washed, and substrates were added. Two substrates were used: 3.3',5,5' 
tetra methylebenzidine (TMB; Kirkegaard and Perry Laboratories, Gaithersburg, MD) and 
the Enhanced Chemiluminescence substrate (ECL; Amersham Life Science Inc., Arlington 
Heights, IL). Molecular weight estimates were made by comparing the mobility o f the 
tested samples with that of the standard protein mixture(Bio-Rad Laboratories Inc.) 
separated on the same gel.
RESULTS: 
Detection of coproantigen:
The presence o f coproantigen in the feces of experimentally infected calves was 
determined by WB. Since the four MAbs react identically with the 26- 28 kD band o f the 
ES, ES was used as a positive control. Known negative fecal samples were used as a 
negative control. By WB using culture supernatants containing MAbs and TMB, the 
colorometric substrate, a 26-28 kD band was detected in the ES, but the assay was not
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sufficiently sensitive to detect the band in the fecal samples (Fig. 2.1). However, the 26-28 
kD band was detected using the culture supernatant containing MAbs and ECL, the 
chemiluminesent substrate (Fig. 2.2). When MAbs purified from ascites fluid were used 
with the colorimetric substrate TMB, the 26-28 kD band was detected in both the ES 
product and in the feces from infected cattle. The sensitivity o f the assay was increased 
further when the ECL substrate was used. To further increase the sensitivity o f detection, 
biotin-streptavidin modification was used with both TMB and ECL substrates. Using TMB 
substrate, the biotin-streptavidin modification enhanced the detection o f the coproantigen, 
however the noise level with ECL increased substantially, resulting in problems with 
background. I found that the indirect WB using the purified MAbs and the biotin- 
streptavidin WB were sufficiently sensitive; therefore, this assay system was used to 
determine the specificity the MAbs, and for tests on fecal supernatants from infected cattle 
with known number of flukes to determine the relative sensitivities of the MAbs. 
Specificity of the MAbs :
F. hepatica often coexists with other trematode, nematode and cestode parasites 
in naturally infected cattle. To determine the specificity of the MAbs for F. hepatica 
coproantigen, WB were performed using FFA and the ES of F. hepatica, F. gigantica, 
Fascioloides magna, Paramphistomum microbothioirdes and Moniezia sp. All 4 Mabs 
reacted strongly with F. hepatica. The MAbs showed weak cross-reactivity with F. 






Fig. 2.1. Detection o f coproantigen with MAb (F10) supernate using western 
blot analysis and TMB substrate; lane (1) F. hepatica ES product as positive 
control. Feces from calves infected with the following numbers of flukes; lane 







Fig. 2.2. Detection of coproantigen with MAb (F10) supemate using western 
blot analysis and ECL substrate; lane (1) F. hepatica ES product as a positive 
control, lane (2) feces from a calf infected with 39 flukes and lane (3) negative 
control feces.
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reactivity was observed with the rumen fluke P. microbothioirdes or the cestode parasite 
Moniezia sp. (Fig. 2.3, Table 2.1).
Determination of the sensitivity of the MAbs:
The ultimate goal of this study was to develop a more sensitive procedure for 
detection of sub-clinical F. hepatica infection. To determine the sensitivity o f the WB for 
coproantigen, feces from calves experimentally infected with 39, 28, 22, 10, 6 and 0 
flukes were examined. WB were probed with either purified MAbs (indirect WB), or 
biotinylated MAbs (biotin-strepavidin WB). The indirect WB detected as few as 22 flukes 
(Fig 2.4). When the biotin-streptavidin WB were used, as few as 10 flukes were detected 
(Fig. 2.5). I observed that the 26-28 kD band intensity increased with increasing fluke 
burdens (Fig. 2.4, 2.5). The 26-28 kD band was not detected in feces from animals with 
fluke numbers less than 10 using either assay.
To determine whether the MAbs can detect the F. hepatica infection before egg 
laying begins by mature flukes, Streptavidin WB were performed using MAb F10 on feces 
from animals infected with 39 ,32,28,22 and 10 flukes at 6, 8, and 13 week after infection. 
The antigen was detected in all 5 animals as early as 6 weeks post- infection. Maximum 
coproantigen concentration as determined by band intensity was seen at 8 weeks after 
infection. A representative blot is shown in Fig. 2.6. These results were compared to the 
number o f eggs recovered by fecal sedimentation. Eggs were not recovered by fecal 
sedimentation from any of the calves at 6 or 8 weeks post-infection; eggs were found in 4 
o f 5 calves at 13 weeks post-infection (Table 2.2).
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Fig. 2.3. Determination o f the specificity of the Mabs for F. hepatica 26-28 kD 
antigen. Representative western blot analysis usisg MAb F 10: Lane (1) F. 
magna ES, lane (2) F. hepatica ES, lane (3) F. gigantica ES, lane (4) 
Paramphistomum sp. and lane (5) Moneizia sp.
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Table 2.1. Determination o f the cross-reactivity o f the four monoclonal antibodies to 
common trematode and cestode parasites o f cattle.
Reactivity o f the four monoclonal antibodies8
10 G7 E7 F7
F. hepatica ++++ -H-++ -H--I !■ Mi l -
F. gigantica + + + ++
F. Magna +++ +++ ~H~+ +-H-+
P. microbothrioides - - - -
Moneizia sp. - - - -








Fig. 2.4. Detection of F. hapatica coproantigen with purified Mab (F10) using 
western blot analysis and TMB as substrate; lane (1) F. hepatica ES product 
as positive control. Feces from calves infected with the following numbers of 
flukes: lane (2) 39, lane (3) 32, lane (4) 28 and lane (5) negative control feces.
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Fig. 2.5. Detection o f coproantigen using a biotin-streptavidin modification 
o f the WB and TMB substrate. Lane (1) F. hepatica ES product as positive 
control. Feces from calves infected with the following numbers of flukes: lane 
(2) 39, lane (3) 32, lane (4) 28, lane (5) 22, lane (6) 10 and lane (7) negative 
control feces.
Fig. 2.6. Kinetics of coproantigen appearance measured by WB using a biotin 
streptavidin modification and TMB substrate. Feces from infected calves at; 
lane (1)6  weeks, lane (2) 8 weeks (3), 13 week post-infection and lane (4) pre­
infection fecal supernatant.
Table 2.2. Kinetics of the appearance of the 26-28 kD coproantigen in feces of experimentally-infected cattle detected by 
western blot and compared to the number of eggs .
Number of flukes
Diagnosis at weeks post infection
6week 8week 13 wee
Mat3 Immb Total Eggsc WBd Eggs WB Eggs WB
38 1 39 0 +++ 0 ++++ 7 +++
25 7 32 0 +++ 0 ++++ 2 +++
26 2 28 0 +++ 0 ++++ 4 +++
22 0 22 0 ++ 0 +++ "* ++
7 3 10 0 + 0 ++ 0 +
a. Mature flukes.
b. Immature flukes.




The presence of parasite specific antigen in the feces an infected host has recently 
received considerable attention as a means o f diagnosing o f a number o f parasites (Craft 
and Nelson, 1982; Green et al., 1995; Rosoff and Stibbs, 1986; Ungar, 1990; Allan et al., 
1992; Sirisinha et al., 1991; El-Bahi el al., 1992; Deplazes et al., 1992; Ellis et al.,1993, 
Deplazes etal.,1994, Espino and Finlay, 1994). The 26-28 kD of F. hepatica coproantigen 
was previously detected using polyclonal antibodies by WB (El-Bahi et al., 1992). In this 
study I report early detection o f coproantigen in subclinically infected cattle using MAbs 
generated to the 26-28 kD coproantigen. Using WB with the colorimetric substrate TMB, 
supernatant fluid of these MAbs reacted with the corresponding 26-28 kD band of the ES 
but were not concentrated enough to reveal the band in the feces. However, the band was 
detected in the feces using ECL substrate which indicated that the ECL substrate is more 
senstive than the TMB. By using purified Mabs which contain a higher antibody 
concentration, the 26-28 kD coproantigen was detected in the feces o f animals infected with 
as few as 22 worms. To further enhance the detection a biotin-streptavidin modification of 
the WB using TMB and ECLwas developed. Using TMB biotin-streptavidin WB was 
sensitive enough to detect as few as 10 flukes. The bands were clear with low background. 
The increased noise associated with the biotin-streptavidin WB and ECL made ECL 
impractical. I concluded that the most sensitive detection of the coproantigen was achieved 
using the biotinylated MAbs and TMB substrate, and this procedure was standardized for 
the remainder of the study.
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In a production setting, cattle are often co-infected with other parasites. I wanted 
to determine if  this assay was specific for F. hepatica', therefore, FFA and ES o f other 
trematode and cestode parasites that commonly occur in cattle or that are related to F. 
hepatica were used as antigen in WB. I was specifically interested in P. microbothriodes 
because its eggs are sometimes confused with the F. hepatica eggs in routine fecal 
sedimentation examinations. In this assay,I found that the MAbs did not recognize antigens 
in the ES of P. microbothriodes. I believe this test will differentiate between the infection 
with liver flukes and the rumen fluke. I also did not observe cross-reactivity with the 
cestode parasite Moniezia sp. Minimum cross-reactivity was observed with ES of F. 
gigantica , which is found in tropical and subtropical regions o f the world and therefore 
should not be a problem in North America. The Mabs also cross-react with the ES o f F. 
magna, a deer liver fluke that sometimes incidentally infects cattle in ranges shared with 
deer. However, cattle are an abnormal host, and intense fibrotic encapsulation of F. magna 
typically prevents shedding o f eggs into the feces. Further investigation is needed to 
determine if  these antigens are excreted in the feces and if  these antigens can be detected 
in the feces by these MAbs. Espino et al. (1994) detected a coproantigen in the feces of 
human patients shedding between 25 and 269 F. hepatica eggs per gram of feces using a 
MAb-polyclonal antibody capture ELISA. They found a positive correlation between the 
Fasciolaegg count and stool antigen concentration. In the present study, I did not correlate 
the intensity of the 26-28 coproantigen to the number o f eggs; however, this study was 
short and dealt with low fluke counts. In this study the egg counts were not reliable and
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did not indicate the actual number o f flukes because immature flukes do not shed eggs 
(Table 2.2). Unlike the egg counts, I found that the number o f flukes and the intensity of 
reaction in the 26-28 kD coproantigen band were correlated. Using the biotinylated MAbs, 
the 26-28 kD band was detectable in the feces of infected animals with as few as 10 flukes. 
Fluke burdens of 20 flukes or less are generally considered to be sub-clinical infections 
and are often undiagnosed with the fecal egg count procedure in cattle.
Acute fascie . is is often undiagnosed because F. hepatica flukes mature and begin 
shedding eggs 8 w after infection while the acute symptoms occur earlier (Hillyer, 1986). 
Prepatent detection o f F. hepatica infection might be helpful in controlling the disease with 
drugs directed specifically toward the immature flukes, preventing further damage o f the 
liver parenchyma by migrating flukes. Serological assays have been shown to detect F. 
hepatica as early as 2-4 week post-infection (Zimmerman et al., 1985) but these assays do 
not necessarily indicate active infection since the antibody level in previously infected hosts 
can persist after treatment. Moreover, antibodies were not detected in animals infected with 
less than 27 flukes (Langley and Hillyer, 1989b). Methods for the detection o f fasciolosis 
circulating parasite antigen (Langley and Hillyer, 1989a; Langley and Hillyer, 1989b; 
Rodrigue-Perez and Hillyer, 1995) only indicate active infection and could detect the 
acute subclinical infection; however, these circulating antigen could not be detected once 
the flukes were established in the bile duct (Langley and Hillyer 1989b). In addition, 
collection o f blood samples for these tests require animal restraint which is often 
inconvenient especially for herd evaluations. The assay described here detected
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coproantigen in the feces of experimentally-infected calves as early as 6 weeks post­
infection. Maximum coproantigen concentration was seen at 8 weeks post-infection. This 
corresponds to the finding of Langley and Hillyer (1989b), and Rodrigue-Perez and Hillyer 
(1995) for the detection of the circulating antigen in cattle and sheep. In addition, WB was 
sufficiently sensitive to detected 10 flukes and collection fecal samples does not require 
individual animal restraint.
The ability o f the WB to detect the antigen before egg shedding suggested that the 
26-28 kD coproantigen is not an egg-related antigen. Future studies o f the coproantigen 
will concentrate on localization of the antigen in the flukes, as well as determination of 
the chemical nature and stability of the coproantigen. Fecal samples used in this study were 
held longer than 1 year at -20°C, suggesting that the coproantigen is stable. The stability 
o f the coproantigen may make it possible to collect fecal samples directly from the pasture 
without animal contact, that greatly simplifying herd evaluation proceedures.
CHAPTER III
BIOCHEMICAL CHARACTERIZATION AND LOCALIZATION OF 
FASCJOL4 HEPATICA 26-28 kD DIAGNOSTIC COPROANTIGEN 
INTRODUCTION:
A variety o f antigens are secreted and excreted by parasites and are present in the 
blood, feces, urine and other fluids of the infected host. These antigens have potential for 
use in immunodiagnosis and vaccine development. Several diagnostic parasite antigens 
have been chemically and immunologically characterized. Schistosoma mansoni 
circulating antigens, characterized as polysaccharide by Nash et al. (1974), were shown to 
be o f two types: circulating cathodic antigen (CCA) and circulating anodic antigen (CAA) 
(Deedler et al., 1976). Both CAA and CCA have been reported to be gut-associated 
glycoproteins (Nash and Deelder, 1985; Deedler et al., 1985) and several ELISA assays 
based on the detection o f these schistosome circulating antigens have been developed 
(Deedler, et al., 1989; de Jonge et al., 1990 and Hassan et al., 1992). Among cestode 
parasites, March et al. (1991) chemically characterized two Echinococcus granulosus 
antigens of serodiagnostic value, an N-glycosylated glycoprotein and a polypeptide. Using 
MAb, Draelants et al. (1995) characterized an epitope o f a circulating antigen with 
immunodiagnostic value in the ES of Taenia saginata. They reported that the epitope is 
either a carbohydrate or a glycoprotein and that this antigen is present in the tegument of 
the worm. Studies on the chemical and physical properties o f a coproantigen o f the
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protozoan parasite Giardia lamblia by Rosoff and Stibbs (1986) indicated that the 
coproantigen is a highly glycosylated glycoprotein which is resistant to proteolytic 
digestion but sensitive to treatment with sodium periodate.
Although diagnostic assays for fasciolosis have been described for detection of 
either circulatory antigens (Zimmerman et al., 1985; Langley and Hillyer, 1989b; Rodrigue- 
Perez and Hillyer, 1995) or coproantigen (El-Bahi et al., 1992; Espino et al., 1994) little is 
known about the physical and chemical nature of these antigens. The previous chapter 
described the detection o f a 26-28 kD coproantigen using Mabs raised against this 
particular molecule. Knowledge o f the chemical nature, stability and origin o f this 
coproantigen is needed for development of improved immunodiagnostic assays. In this 
study I biochemically and immunologically characterize the 26-28 kD coproantigen and 
localize the antigen on mature and immature flukes recovered from bile ducts by 
immunofluorecence using MAbs.
MATERIAL AND METHODS: 
Monoclonal antibodies and Western blot analysis :
The 4 MAbs F10, G7, E7 and F7 were used for the characterization o f the 
coproantigen. The generation of the MAbs and the WB analysis were performed as 
described in Chapter II.
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Excretory-secretory product (ES)
Fasciola hepatica ES product was prepared as described by Santiago and Hillyer 
(1986) and is reviewed in Chapter II.
Gel fdtration chromatography ( Sepharose G-75).
The coproantigen was purified from the other ES components using a 0.77x50 cm 
glass Econo-column (Bio-Rad Laboratories Inc.) packed to a bed height o f 40 cm with 
Sephadex G-75 superfine beads (Pharmacia Biotech Inc, Picataway, NJ). The column was 
calibrated using a Pharmacia Gel Filtration Kit for molecular weight determination o f low 
molecular weight proteins (Pharmacia Biotech Inc.). PBS was used for the fractionation 
of F. hepatica ES product. Four mg of concentrated ES in 1 ml PBS were applied to the 
column followed by 1ml o f 1% methyl green (Sigma Chemical Co., St.Louis, MO) in PBS. 
The complete Econo System (Bio-Rad Laboratories, Inc.) was used in the fractionation 
at a flow rate o f 22 ml/h. Fractions were collected in 0.5 ml volumes and were examined 
for the presence o f the coproantigen by WB.
Differential staining:
The chromatographically purified 26-28 kD antigen was diluted in sample buffer 
under reducing and non-reducing conditions. All samples were boiled at 100°C for 5 m, 
then separated on a 12% acrylamide SDS-PAGE gel by the method o f Laemmli (1970). 
Gels were then stained with: 1) Coomassie blue stain (Sigma Chemical Co.); 2) silver stain 
(Bio-Rad laboratories Inc.); 3) periodic acid Schiff reagent stain (PAS; Polyscientific 
Research and Development Corp., Bay Shore, NY.) and 4) PAS silver stain. Coomassie
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staining was done according to the method o f Hames 1990. A Bio-Rad Silver Stain Kit 
was used for silver staining o f the gels according to the manufacturer’s instructions for 
staining 0.5-0.1 mm gels. The PAS staining was performed according to the method of 
Jay et al. (1990). Briefly, gels were fixed in 50% (v/v) methanol with gentle agitation, 
incubated for 20 min in distilled water, and then incubated in 2% sodium periodate (Sigma 
Chemical Co.) for 15 min. After two 2 min washes with distilled water, concentrated 
Schiff reagent was added and the gels were gently agitated in a fume hood for 2 hr to 
overnight. The gels were destained by washing in several changes of distilled water until 
the background faded and the bands appeared magenta in color. PAS-silver staining was 
done according to the method o f Jay et al.(1990). Briefly, after staining with PAS, the gels 
were washed twice with distilled water and reduced with 2% (w/v) sodium metabisulfate 
(Sigma Chemical Co.) in distilled water overnight The gels were then washed for 30 min 
with several changes o f distilled water until the water remained clear and then silver stained 
as described above.
Alkaline treatment and enzymatic deglycosylation:
Purified coproantigen was brought to pH 10 using 0.1M NaOH and incubated in 
the dark overnight at 37°C . The pH was neutralized by the addition o f 0.1 M HC1 prior to 
analysis by WB. Enzymatic deglycosylation was performed on the purified antigen by 
using endoglycosidase F and endoglycosidase H (EndoF and EndoH; Boehringer 
Mannheim Biochemica. GmbH, Germany) as described by the manufacturer. For Endo 
F treatment, 4pg o f chromatographically purified 26-28 kD antigen was diluted 1:5 (v/v)
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in lOOmM sodium phosphate, 25mM EDTA, 5mM sodium azide and 50%, v/v, glycerol, 
pH 7.2 and boiled for 1 min. To 90 pi of the mixture, 0.5% Triton X 100, 1% 2-ME and 
1 U o f EndoF were added. After an 18 hr incubation at 37°C an additional 0.4 U o f Endo 
F were added and incubated for an additional 3 hr. For Endo H treatment, purified 26-28 
kD antigen was diluted 1:5 (v/v) 50 mM sodium phosphate buffer, 25mM EDTA, 0.05% 
(w/v) sodium azides pH 7 boiled then boiled for 1 min. To the mixture, 1% triton X 100 
and 7% 2-ME were added, followed by the addition of 10 pU of Endo H. After 18 hr 
incubation at 37°C, an additional 2 pU o f EndoH were added and incubated for an 
additional 3 hours. Purified antigen treated as above but without the addition of the 
enzymes served as controls.
Ion exchange chromatography:
Excretory secretory product components were separated using a 0.77x50 cm glass 
Econo-column (Bio-Rad Laboratories, Inc.) packed to a bed height o f 20 cm with Q 
Sepharose Fast Flow (Pharmacia Biotech Inc. , Picataway, NJ). Four milligrams of ES 
protein in 1 ml 25 mM NaCl was applied to the column. Gradient elution was performed 
to release bound molecules using NaCl at molarities of 25mM to 500mM. Fractionation 
was performed using the Complete Econo System (Bio-Rad) at a flow rate o f 2 ml/min. 
Collected fractions were tested for the presence of the antigen by WB.
Gelatin SDS-PAGE:
The method o f Dalton and Hefferman (1989) was used. Briefly lOpg o f purified 
26-28 kD coproantigen was applied to a 12% acrylamide gel with the following
45
modification: both the stacking and separating gels contained 0.1% bovine gelatin (Sigma 
Chemical Co.). Ten units pronase E and 10 U trypsin (Sigma Chemical Co.) were used as 
controls. Gels were washed for 1 lor in the incubation buffer (see below) containing 2.5% 
Triton X-100 with one change, then incubated in the incubation buffer alone for 16 hour 
. Four different incubation buffers were tested: 0.1 M glycine, pH 8.0; 0.1 M glycine pH 
7.0; 0.1M sodium citrate, pH 4.5 and 0.1M sodium citrate, pH 3.0. Following incubation, 
gels were stained with 0.04% Coomassie brilliant blue dissolved in stacking solution (20% 
methanol: 10% acetic acid: 70% water) and destained in the same stacking solution. 
Protease digestion:
The proteolytic sensitivity of the coproantigen was determined by incubation with 
pepsin, trypsin and pronase E (Sigma Chemical Co. ) according to Rosoff and Stibbs 
(1986). Pepsin and trypsin were used at a concentration of 2000 U/ml in 0.1 M Tris 
hydrochloride, pH 8.0. The 26-28 kD protein was digested for 24 hours at 37°C. Pronase 
E was used at a concentration o f 100 U/ml in 0.1 M Tris hydrochloride, pH 8.0 containing 
1 mM CaCl2. The purified 26- 28 kD protein was incubated for 15 min at 37°C followed 
by digestion at 60°C for 24 h. As a control, the 26-28 kD protein was incubated in 0.1 M 
Tris hydrochloride, pH 8.0 alone. After digestion all the samples were evaluated by SDS- 
PAGE and WB as described above.
The effect of temperature on the antigen :
To determine the effect of temperature on the antigenicity of the coproantigen, the 
26-28 kD antigen was incubated for 15 min in a heat block at 100°C or overnight, for 3
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days or for lw k at room temperature and incubated for up to 2 month at 4°C. All the 
incubations were terminated by boiling the antigen in SDS-PAGE sample buffer, and the 
effect of these incubations were evaluated by SDS-PAGE and WB.
Indirect immunofluoresence :
The four MAbs (F10, G7, E7 and F7) specific for the 26-28 kD coproantigen were 
used to localize the coproantigen on cross sections o f the flukes. Murine IgM, k  Protein 
Control (Hyclone Laboratory Inc., Logan,UT) was used as a control. For preparation of 
the fluke sections, living flukes were collected from the bile ducts o f infected cattle at 
necropsy and placed into RPMI media. Flukes were frozen by Cryokwik (International 
Equipment Company, Needham height, MA.). Frozen cross sections o f the flukes were 
prepared and later fixed in acetone: ethanol solution (1:1) for 5 min at - 20°C. Slides were 
washed twice with PBS. Each of the four MAbs and the mouse IgM, k  protein control 
were diluted separately to lpg/m l in PBS contains 1% bovine serum albumin (Sigma 
Chemical Co.) and 5% normal goat serum (Sigma Chemical Co.; dilution buffer). The 
fixed slides were immersed in the diluted MAbs for 1 hr at room temperature with gentle 
shaking. The slides were then rinsed with PBS followed by a 10 min wash with PBS with 
gentle shaking. The sections were then immersed in a 1:100 dilution o f DTAF-labeled 
anti-mouse IgG (Jackson Immuno Research Laboratories, Inc., West Grove, PA.) in the 
dilution buffer and incubated with gentle agitation for 1 hr. Sections were washed as above 
and counter stained with 0.1% Evan’s blue (Sigma Chemical Co.) in PBS for 5 min, 
washed with distilled H20  and mounted with 0.5% glycerol in PBS prior to examination.
RESULTS: 
Purification of F.hepatica antigen by gel filtration:
Because the coproantigen is found in low concentration in the feces and feces is 
highly contaminated with organic materials, the MAbs recognize the 26-28 kD molecule 
in the ES by WB and the molecule is present at relatively high concentrationin ES; 
therefore, I choose to used F. hepatica ES as a source o f the 26-28 kD coproantigen for the 
biochemical studies. I was unable in several attempts to purify the 26-28 antigen from ES 
by affinity chromatography using the MAbs; therefore, I purified the coproantigen by gel 
filtration using G-75 superfine column. When the concentrated ES was fractionated on the 
calibrated column, two major peaks and one small peak were resolved. The purity of the 
fractions was analyzed by SDS-PAGE. The first peak was the void volume which contain 
the higher molecular weight proteins. The only band that was detected in the second peak 
was the 26-28 kD antigen and this antigen was recognized by the MAbs using WB (Fig. 
3.1). Comparing the peaks from ES to those of the calibration kit, the coproantigen peak 
was found between the 25 kD peak and 13 kD peak with a predicted MW by 
chromatography o f 18 kD ( Fig. 3.2 ).
Differential staining of coproantigen:
Since different molecules have different staining properties, the staining properties 
o f the coproantigen in ES were investigated. Results are shown in Fig 3.3. When gels were 










Fig. 3.1. Differential stains and western blot analysis o f chromatography 
purified 26-28 kD antigen; lane (1) SDS-PAGE gel stained with Commassie 
blue, lane (2) silver stain, lane (3) PAS, and lane (4) reacted with the specific 














Fig. 3.2. Sephadex G-75 (superfine) gel filtration elution profile of the 26-28 
kD antigen from ES. (A) Calibration o f the column with commercial protein 
standards and (B) F. hepatica ES.
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Fig. 3.3. Differential staining of SDS-PAGE separated ES o f F. hepatica 
showing the 26-28 kD coproantigen. Lane (1) stained with commassie blue, 
lane (2) stained with silver stain, lane (3) stained with PAS stain and lane (4) 
stained with PAS-silver stain.
with silver stain, other proteins found in ES product were stained and the 26-28 kD antigen 
was negatively stained which suggested that the antigen might be a glycoprotein. To 
confirm the silver stain results, the PAS staining profile o f the coproantigen was 
investigated. I found that the band stained clearly with PAS indicating that the molecule 
was a glycoprotein. A PAS-silver stain, which stains glycoproteins but not proteoglycan 
(Jay et al., 1990), was then performed and the 26-28 kD band remained unstained. There 
were no differences between the size o f the band under reducing and non-reducing 
conditions (Fig 3.4). Results were confirmed by similar differential staining of the purified 
26-28 kD coproantigen. These results indicated that the coproantigen is a monomeric, 
highly glycosylated glycoprotein, and most probably it is a proteoglycan.
Alkaline treatment and enzymatic deglycosylation:
Since the differential staining indicated the coproantigen molecule is a 
proteoglycan, attempts were made to identify the type of the glycosylation. Alkaline 
treatment o f the coproantigen resulted in the disappearance of the 26-28 kD band and 
appearance of a new band with a MW of 8 kD in a coomassie blue stained gel. The 8 kD 
band was recognized by all four MAbs on WB, a representative WB is shown in Fig. 3.5. 
Neither Endo F nor Endo H had an effect on the size or the antigenicity o f the 26-28 kD 
band (Fig 3.5). These results suggest that the coproantigen is an O-glycosylated protein in 
which 70% of its size is a carbohydrate. Further the specific epitope recognized by the 











Fig. 3.4. Commassie blue stain ofthe 26-28 kD coproantigen on SDS-PAGE 
under reducing and non-reducing conditions. Lane (1) reducing condition and 
lane (2) non-reducing condition.
Fig. 3.5. The effect of the alkaline treatment and enzymatic deglycosylation on 
the coproantigen as detected by the specific MAb F10 by WB. Lane (1) 
untreated, lane (2) alkaline-treated, lane (3) Endo F-treated and lane (4) Endo 
H-treated 26-28 kD antigen.
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Charge of the coproantigen:
To determine the charge o f the coproantigen, Q Sepharose Fast Flow Anion 
exchange chromatography column was used. The results are shown in Fig. 3.6. While the 
major part o f the 26-28 kD antigen was eluted with the void volume at 25 mM NaCl, a 
portion o f the coproantigen was later eluted in at 250-375 mM NaCl . These results 
indicate differences in the charge o f the coproantigen which could be attributed to the 
differences in glycosylation.
Protease activity of the coproantigen:
Many previous studies reported proteolytic enzymes in the products released by 
tissue penetrating parasites. To determine if the 26-28 kD coproantigen plays any role in 
penetration of the liver parenchyma, the protease activity o f the purified antigen was 
analyzed by gelatin SDS-PAGE . After electrophoresis, gels were incubated individually 
at pH 8.0,7.0,4.5 or 3.0. No protease activity was detected for the coproantigen at any pH, 
while at pH 7.0 and 8.0 both protease and trypsin digested the gelatin, resulting in clear 
areas when stained with Coomassie blue (Fig 3.7).
Sensitivity of coproantigen to the proteolytic enzymes:
The coproantigen characterized in this study is secreted and excreted by the flukes 
in the bile duct. This protein moves through the digestive tract where it is subjected to 
different digestive processes, including proteases. The sensitivity o f the coproantigen to 
pepsin, trypsin and pronase E was examined. The purified 26-28 kD protein was digested 
with enzymes and analysed by SDS-PAGE and WB. While the purified coproantigen was
Fig. 3.6. Western blot analysis of fractions from ion exchange chromatography 
o f the ES using Q Sepharose. Lane (1) unseparated ES as a control. Fractions 
collected at: lane (2) 25 mM, lane (3) 50 mM, lane (4) 125 mM, lane (5) 250 
mM, lane (6) 375 mM and lane(7) 500 mM.
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7 1 , 0 0 0
4 1 , 8 0 0
3 0 , 6 0 0
1 7 , 8 0 0
6 , 9 0 0
^Copro
antigen
Fig. 3.7. Determination o f protease activity o f the 26-28 kD antigen using 
Gelatin SDS-PAGE, stained with Commassie blue. Lane (1) trypsin, lane (2) 
pronase E as controls, and lane (3) is the 26-28 kD antigen.
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not affected by the proteolytic activity of pepsin and retained its reactivity with the specific 
MAbs, the coproantigen was sensitive to pronase E and trypsin. After digestion with 
pronase E no band could be detected by WB indicating that pronase E destroyed the 
reactive epitope. After partial digestion with trypsin the 26-28 kD band became fainter in 
WB and another molecule was created that was recognized by the MAbs. The new 
molecule had a molecular weight of 18 kD (Fig 3.8). The 26-28 kD molecule in ES was 
also resistant to treatment with pepsin and degraded by pronase E, however, after treatment 
with trypsin, the MAbs recognized two bands: the first was the 18 kD band, and the second 
is a new 40 kD band (Fig. 3.8). These result indicate that the antigenicity o f the 
coproantigen is not affected by pepsin or trypsin but it is sensitive to pronase E which 
confirms the protein nature o f the epitope. Further it indicates that the epitope is created 
or exposed on a larger molecule following treatment with trypsin.
The effect of temperature:
Since the 26-28 kD antigen detected in feces will be used in a diagnostic test for 
F. hepatica, attempts were made to determine tire stability o f the coproantigen. Boiling of 
the 26-28 kD coproantigen has no effect on the size and antigenicity o f the molecule (data 
not shown). The effect of temperature on coproantigen was evaluated by SDS-PAGE 
followed by Coomassie stain and by WB against the specific MAbs (Fig. 3.9). Overnight 
incubation o f the antigen at room temperature gave rise to several new smaller MW bands 
ranging from 20- 8 kD and the incubation of the antigen at 4°C for 2 month generated a 
smaller band around 20 kD; this band decreased in size after longer incubation. All o f the
Fig. 3.8. The effect of protease treatment on purified 26-28 kD antigen and ES as 
detectedusing specific MAb F10 in WB. Protease treatment o f (A) purified 26-28 kD 
antigen and (B) F. Hepatica ES. Lane (1) untreated coproantigen, lane (2) pepsin digested 










Fig. 3.9. The effect o f different storage temperature on stability of coproantigen as 
detected usingMAb F10 in WB. The 26-28 kD antigen stored lane (1) more than 3 
years at -20°C, lane (2) for 2 months at 4°C and lane (3) overnight at room temprature.
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new bands were recognizable by the MAbs. From these results, I concluded that the 
coproantigen was relatively stable at different storage temperatures and even when the 
molecule was degraded antigenicity was maintained.
Localization of coproantigcn on the adult fluke:
Using three o f the MAbs (F10, G7 and E7) separately as the primary antibody in an 
indirect immunofluorescent antibody assay on frozen sections of the adult worms, a strong 
fluorescence was observed in the tegument and the gut. For the MAb F7, florescence was 
noted only in the gut of the adult worm. No florescence was observed for the mouse IgM 
protein that was used as a control (Fig. 3.10). These results suggests that the source o f the 
coproantigen is present in the tegument and the gut of the flukes.
DISCUSSION:
A 26-28 kD coproantigen was detected in the feces on of the cattle using polyclonal 
antibody or MAbs in WB (El-Bahi et al.1992), but the biochemical nature o f the antigen 
was unknown. Characterization of the nature of this antigen, where it is produced, and its 
stability to environmental and enzymatic degradation, are important for development o f an 
effective diagnostic test. The 26-28 kD antigen is highly diluted in the feces and would be 
difficult to purify from other organic and non-organic materials contained withen the feces; 
therefore I chose to work with F. hepatica ES which contains a molecule o f the same 
molecular weight and antigenicity as the coproantigen and is available at higher 
concentration.
Fig. 3.10. Localization of the coproantigen on cross sections of mature F. hepatica 
using indirect immunofluorescent antibody. Panel (A) the tegument and panel (B) 
the gut o f the fluke xlOO.
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Several attempts were made to purify the 26-28 kD antigen using the MAbs but 
were unsuccessful. The low affinity of the IgM MAbs might be the reason; however, the 
four MAbs were noted to bind with higher affinity to the denatured molecule than to the 
native molecule which may explain the problems with the affinity purification. Therefore, 
the 26-28 kD antigen was purified by gel filtration. Comparing the antigen peak to the gel 
filtration molecular weight standards I estimated that antigen had a molecular weight of 18 
kD (Fig 3.1) while its molecular weight was estimated at 26-28 kD by SDS-PAGE. Gel 
filtration is a poor method for estimating the molecular weight of glycoproteins containing 
more than a few percent of carbohydrate due to their asymmetric branched structure (Beely, 
1985). These results suggest that the antigen is a compact molecule which behaves as 18 
kD protein on gel filtration. Further, biochemical analysis o f the 26-28 kD antigen under 
reducing and non-reducing conditions, indicated that the coproantigen exists as a monomer.
Little or no silver staining is observed for those glycosylated proteins o f which 
50% or more of their molecular weight is carbohydrate, most probably due to stearic 
interference of the carbohydrate with the binding with silver (Jay et al.,1990). The pattern 
o f staining o f the 26-28 kD coproantigen with Coomassie blue and PAS stains and the 
negative staining with silver stain indicated that the molecule is a highly glycosylated 
protein. The PAS-silver stain is a sensitive method for the staining o f glycoprotein, 
however, it fails to stain proteoglycan (Jay et al., 1990). The failure of the 26-28 kD band 
to stain with PAS-silver stain suggests that the molecule is a proteoglycan. After identifying 
the molecule as a proteoglycan, I examined the type o f glycosylation. The release of
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carbohydrate units by alkali has been most widely applied to glycoproteins and proteoglycans 
containing alkali-sensitive O-glycosidic linkages. At high pH, the O-glucosidic linkage 
between glycan and 5-hydroxyamino acid of serine and threonine are cleaved (Beely 1995). 
When the pH of the purified coproantigen was increased to pH 10 the 26-28 kD band was 
no longer found in the stained gel and could not be detected in WB. Concurrently, a smaller 
band of MW of 8 kD appeared and was recognized by the specific MAbs. This indicated 
that the coproantigen might be O-glycosylated. However, other workers have shown that 
even the mild alkaline treatment of glycoproteins or proteoglycans under conditions severe 
enough to release O-linked oligosaccharide will also liberate many N-linked glycans. To 
eliminate the possibility o f being N-linked, the coproantigen was subjected to enzymatic 
deglycosylation using EndoF and EndoH. These enzymes act on the asparagine-linked 
carbohydrate groups of glycoprotein. The coproantigen was stable under these enzymatic 
deglycosylations as described here; However, since 70% of the MW of the antigen is 
carbohydrate, it is possible that the large carbohydrate moieties prevented the from reaching 
their cleavage sites. Due to variability in glycosylation, glycoproteins may show evidence 
o f polydispersity o f molecular weight, which result in broad peaks in gel filtration elution 
profiles and a broad bands on SDS-PAGE (Beely 1985). The 26-28 kD antigen gave this 
characteristic polydisperse pattern, and gave different peaks based on charge on the ion exchange 
chromatography.
Like many other helminthic parasites that penetrate the tissue of the host by the action 
of the proteolytic enzymes, F. hepatica releases enzymes that help the parasite in its migration
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from the intestine to the liver where it continues to migrate until it reaches its final habitat, 
the bile duct. Dalton et al. (1989) identified 11 distinct proteases in in-vitro cultures o f F. 
hepatica that play a role in degradation of cells and proteins and penetration o f host tissue. 
Two of these proteins had a molecular weight in the 26-28 kD range (28 and 27.5 kD). To 
determine if the 26-28 kD coproantigen identified by the MAbs is a protease, the SDS-gelatin 
method of Dalton et al. (1989) was applied to the coproantigen. Results indicated that the 
coproantigen is not a protease and that this molecule is unique.
In transit from the bile ducts through the intestinal tract, the coproantigen is exposed 
to digestive enzymes such as pepsin (found in the gastric juice) and trypsin (found in the 
small intestinal digestive fluid), therefore I wanted to determine the effect of these proteases 
on the coproantigen. As with other proteins, prolonged pronase E digestion of the coproantigen 
resulted in very extensive degradation of the peptide chain of the glycoproteins, which resulted 
in the disappearance of the coproantigen band from the stained gel and WB. Results o f this 
study showed that the 26-28 kD antigen is not digested by pepsin, which cleaves peptide 
bonds containing phenylalanine, tryptophane, or tyrosine. However, it was digested by trypsin, 
which cleaves peptide bonds containing lysine or arginine. At least three cleavage sites were 
detected as indicated by the disappearance of the 26-28 kD band and the creation o f four 
new bands o f lower molecular weight. The MAbs detected one o f the new bands at MW 
o f 18 kD, which indicated that trypsin cleaved the molecule without altering the epitope 
recognized by the specific antibody. On the other hand, trypsin treatment o f the ES resulted 
in the detection of the 18 kD band and another band o f higher molecular weight (40 kD)
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. These results suggest that trypsin may have cleaved a previously unrecognized higher MW 
molecule to create a smaller molecule that is recognized by the specific MAbs.
Since the overall goal o f this work is to develop a diagnostic test for detection of 
coproantigen, another important factor which I wanted to address was the stability of 
coproantigen under transport and storage conditions that typically occur when samples are 
submitted to diagnostic laboratories for egg detection. Studies on the effect o f different 
temperatures on the coproantigen revealed that although there are shifts in the band size due 
to either, gradual loss of glycosylation or proteolytic cleavage, antigenicity was retained 
when the ES was left overnight at room temperature, for two months at 4°C and for more 
than three years at -20°C. The same results were obtained using stored fecal samples (data 
not shown) where I observed a shift in the band size after storage 3 years at -20°C. I also 
detected several bands from the stored feces by WB that ranged from the 28 to 8 kD.
Finally I wanted to determine the location of the coproantigen on the flukes themselves 
using the specific MAbs. The tegument of the flukes consists of two main layers, the distal 
and the proximal cytoplasm. The outer zone or the distal cytoplasm where the spines are 
embedded is coated by the glycocalyx which is sloughed continuously. The proximal cytoplasm 
contains tegumental cells (T1 and/or T2 ). These cells are responsible for maintaining the 
glycocalyx. Proximal and distal cytoplasm are connected by tubules underlying these tegumental 
cells and the translocation of the content o f these cells to the distal cytoplasm takes place 
through these connecting tubules. In the newly excysted juvenile the tegumental cells are 
called TO cells. During migration to the liver the TO cells metamorphose into T1 cells which
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secret T1 granules. Upon entering the bile duct as immature flukes, T2 cells start to appear 
and for a transitional period the glycocalyx will be formed by both the T1 and T2 granules, 
followed by a decrease in the number o f T1 cells (reviewed by Reddington et al., 1984). 
Using IFA, I localized the antigen to the cells of the proximal layer of the tegument. Since 
studies were conducted on mature flukes, the source of the coproantigen is most probably 
the T2 cells. The other possible source of the coproantigen is the gut lining o f the flukes. 
Hanna and Trudgett (1983) raised MAbs against the tegumental antigen present in T1 granules 
and glycocalyx of the flukes. In addition to labeling the T1 cells and glycocalyx, these MAbs 
labeled the gut and excretory system of the flukes which indicated that these internal structures 
have antigenicity in common with the tegument. My findings are similar in that I localized 
the antigen to the tegument and the gut of the flukes. In schistosomiasis, the major circulating 
antigens are reported to be gut associated glycoprotein and proteoglycans (de Jonge et al., 
1990). While methods for detection of circulating antigens of Schistosoma rely on the detection 
o f the carbohydrate epitopes of the gut-associated glycoproteins and proteoglycans (Nash 
et al.,1974; Deelder et al., 1980; de Jonge et al., 1988; Deelder et al., 1989; de Jonge et al., 
1990), results on F. hepatica reported here indicate that these MAbs detect the protein core 
o f similar antigens.
In summary, this work has demonstrated that: 1) the 26-28 kD antigen is a monomeric 
proteoglycan which is secreted and excreted from the tegument and the gut o f the flukes; 
2) the antigenicity of the coproantigen is stable or even enhanced by the action of proteolytic 
enzymes found in the digestive tract and 3) the antigenicity o f the coproantigen is stable
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under a variety of standard laboratory storage conditions, suggesting that fresh fecal samples 
can be collected from the pasture for herd evaluation without animal restraint and handling. 
The stability of coproantigen antigenicity may be due to its highly glycosylated nature which 
may protect the protein core. These factors support the use of the 26-28 kD coproantigen 
in an immunodiagnostic test for fasciolosis.
CHAPTER IV
EVALUATION OF A MONOCLONAL ANTIBODY-BASED CAPTURE ELISA 
FOR THE DETECTION OF FASCIOLA 26-28 kD DIAGNOSTIC 
COPROANTIGEN IN THE FECES OF CATTLE.
INTRODUCTION:
Diagnosis of Fasciola hepatica, an economically important parasite o f domestic 
animals, is usually achieved by identifying eggs in the feces. However, by the time eggs 
are produced severe damage in the liver parenchyma could have been occurred. Thus, more 
sensitive diagnostic methods would be very useful for the diagnosis o f fasciolosis. Two 
types o f immunoassay have been developed in an effort toward this goal. One approach 
focused on the detection of antibodies in the serum of infected animals (Farrell et al., 1981; 
Hillyer et al., 1981, Hillyer et al., 1985; Zimmerman el al., 1982; Zimmerman et al., 1985; 
Welch et al., 1987 and Hillyer and Soler de Galanes, 1991). These serological tests succeeded 
in'detecting F. hepatica infection as early as 2-4 weeks post-infection, an advantage over 
the current sedimentation techniques in which worms are not detected before they mature 
and begin egg shedding, approximately 8 weeks after infection. The second approach relied 
on the detection of the circulating parasite antigens. These assays have the advantage of 
detecting only active infections. Circulating antigens can be detected in infected humans, 
mice, cattle and sheep using ELISA (Espino et al., 1990; Langley and Hillyer, 1989a; Langley 
and Hillyer, 1989b; Rodrigue-Perez and Hillyer, 1995). While circulating antigens were
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detected as early as 4-6 weeks post-infection (Rodrigue-Perez and Hillyer, 1995), the detection 
o f circulating antigen has some disadvantages: 1) immunocomplex formation tends to reduce 
the number o f epitopes available for the tests and so decreases the sensitivity (Langley and 
Hillyer, 1989a); 2) once the flukes enter the bile duct their various antigenic products are 
no longer available in the circulation (Hanna, 1980b), and 3) since it requires serum, sampling 
o f large herds is difficult.
Detection of F. hepatica antigens in the feces of the infected host might be a useful 
and convenient method for diagnosis o f fasciolosis and this is support by several studies. 
Youssef et al. (1991) detected a coproantigen o f Fasciola gigantica in human feces using 
counterimmunoelectrophoresis. Using WB, El-Bahi et al.(1992) detected a 26-28 kD 
coproantigen of F. hepatica in the feces of naturally infected cattle. Espino and Finlay (1994) 
reported the detection o f a coproantigen using ELISA from feces o f people infected with 
F. hepatica. Using WB, I detected the 26-28 kD coproantigen in experimentally-infected 
calves using MAbs (Chapter II). Coproantigen detection has advantages over the serologic 
assays in that only the active infections are detected, there is no possibility of immunocomplex 
formation and animal handling is not required to obtain samples scince fresh feces can be 
collected from pastures.
I have demonstrated that the 26-28 kD coproantigen is useful in diagnosis of fasciolosis 
(Chapter II) and that the 26-28 kD coproantigen possesses the characteristics o f a good 
diagnostic coproantigen; the coproantigen is stable in the host gastrointestinal tract and under 
different storage temperature (Chapter III). The antigen is shed by mature and immature
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flukes in the bile duct, making early detection possible, and it is present in detectable quantities. 
However, the WB is a technically complicated assay. In the current study, specificMAbs 
(F10) raised against the coproantigen was used to develop a capture ELISA for the detection 
o f mature and immature liver stages fasciolosis.
MATERIAL AND METHODS:
Antibodies:
MAb M2 DS/DSF10 (F10) specific for the 26-28 kD coproantigen was prepared 
as described previously (Chapter II). P3.2.6.1 myeloma was purchased from ATCC.Ascites 
fluid was produced from the myeloma according to the method o f Gallate (1987).
Rabbit anti-26-28 kD coproantigen was obtained by immunizing two female 7-8 
lb New Zealand white rabbits with the chromatographically purified 26-28 kD coproantigen 
(Chapter III). Two hundred micrograms of coproantigen was emulsified with 0.5 ml of Titer 
Max adjuvant (Vaxcel, Inc., Norcross, GA). For each injection, rabbits were hyperimmunized 
by several subcutaneous and intramuscular inoculations on the dorsal aspect and the hind 
quarter of the rabbit, followed by two similar injections at 15 day intervals. Blood was collected 
7-15 days after the final injection. Serum was pooled and stored at - 20 °C.
Calves:
Yearling cattle were obtained from a fluke free-area and confirmed to be fluke-free 
by fecal egg count using a sieve-sedimentation procedure (Flukefinder, Moscow, ID). Each 
animal was experimentally infected with 500 metacercaria. Feces were collected at 6, 8,
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10, and 13 weeks post-infection. Animals were slaughtered 14 weeks after infection, and 
the number of flukes recovered from each animal was determined by the method o f Malone 
et al.(l 982).
Excretory secretory product and fecal sample preparation:
Excretory secretory product of F. hepatica was prepared as described by Santiago 
and Hillyer (1986) and is reviewed in Chapter II. Fecal egg counts and fecal supernate 
preparation were preformed as described in Chapter II.
Antigen capture ELISA protocol:
The assay was optimized using the ES product of F. hepatica which contains the 
coproantigen and the ES of Paramphistomum microbothroides which is not recognized by 
MAb F10 (Chapter I I ). The optimal dilution o f the polyclonal antibody and the enzyme 
conjugate were determined by checker board titration using negative and positive fecal 
supernatant. The optimum dilution of the polyclonal serum was 1:50 and of the goat anti-rabbit 
IgG horseradish peroxidase conjugate was 1: 500. Flat bottom 96-well Immulon 4 microtiter 
strips (Dynatech Laboratories, Chantilly, VA) were sensitized overnight with 1.5 pgAvell 
saturated ammonium sulphate-purified MAb F10 diluted in 0.1 M carbonate buffer, pH 9.6. 
Strips were incubated at 4°C overnight; afterward the wells were washed 6 times with 0.05M 
Tris, 0.001M EDTA and 0.15 NaCl (NET) containing 0.1% Tween 20 (NET-T). Wells were 
blocked with 200 pi o f the NET containing 3% fish gelatin and 0.2% 1M sodium azides 
(blocking solution). After incubation at room temperature for two hours, wells were washed 
as before and stored at -20°C until use. Fecal supernatant were diluted 1:2 in NET-T contain
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3% fish gelatin and 1% mouse myeloma ascites (dilution buffer), and 100 j_il were added 
to the wells in triplicates. The strips were incubated for 1 hr at room temperature then washed 
8 times as before. One hundred microliters of rabbit anti-26-28 kD coproantigen serum diluted 
1:50 in dilution buffer, were added to each well. The strips were then incubated for 2 hr 
at room temperature. After incubation, wells were then washed 6 times as before and lOOpl 
o f peroxidase-conjugated goat anti-rabbit IgG (H+L) chain (Cappel Laboratories, Cochranville, 
PA.) diluted at 1:500 in the dilution buffer, was added to each well. After incubation for 
one hour, wells were washed 6 times as before and 100 pi o f the TMB substrate (Kirkegaard 
and Perry Laboratories, Gaithersburg, MD) were added to each well. The reaction was stopped 
by the addition o f 50 pi 0.1 M sulfuric acid. Color change was measured at 490 nm using 
Dynatech MR 5000 microplate reader (Dynatech Laboratories). ES o f F. hepatica, ES of 
P. microbothroides and the blocking solution were always included as controls.
To determine the sensitivity of the test, 40 pg of the chromatographically-purified 
26-28 kD coproantigen were diluted in a negative fecal supernatant.
Statistical analysis:
Each assay was done in triplicate. Absorbance readings from wells with the same 
sample were expressed as an average. Inter-assay variation was determined by repeating 
the assay four times on four different days. The sample was defined as positive if the optical 
density (OD) value exceeded the mean o f the negative control feces (pre-infection) plus 
2standard deviations. The difference between the OD values o f the pre-infection and post­
infection o f each fecal sample was calculated and tested using the one-tail paired t test.
RESULTS: 
Coproantigen detection:
The fecal capture ELISA for coproantigen was used to detect the antigen in the fecal 
supernatant o f 27 experimentally infected calves with flukes burdens ranging from 1 -39. 
Pre-infection fecal supernatant were also tested. The post-infection ELISA ODs were 
significantly greater than the pre-infection ODs (one-tailed paired /-test p, 0.05) and mean 
from infected cattle feces were significantly different from those o f control feces (Fig. 4.1). 
In addition, there was an apparent correlation o f fluke number with OD values. (Fig. 4.2).
Idefmed a positive fecal sample as greater than the mean o f the negative controls 
plus 2 standard deviation. Using this criteria for positivity, I detected F. hepatica in infected 
animals with 10 flukes or more. All animals with less than 10 flukes were considered as 
negative using the criteria of this test. The inter-assay variation and the intra-assay variation 
was determined and the results are illustrated in (Table 4.1)
Sensitivity of the test:
To determine the sensitivity of the capture ELISA, chromatographically-purified 
coproantigen was diluted in negative fecal supernatant and the dilutions were tested by capture 
ELISA. Using the OD value o f the negative samples plus 2 SD, I was able to measure 300 
pg o f coproantigen per ml of fecal supernatant (Fig. 4.3).
Kinetics of coproantigen in the feces:
Fecal samples taken at 6,8,10,13 week post-infection from 5 calves with high numbers 






















Fig. 4.1.Optical densities of capture ELISA from infected (n=27) and 
uninfected (n=27) animals. Dotted line represents mean OD of the negative 
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Fig. 4.2. Optical densities by capture ELISA o f fecal samples from 
experimentally-infected calves (n=27) with different numbers o f flukes.
Table. 4 .1 . Representative triplicate results for capture ELISA for coproantigen illustrating inter-assay and intra­
assay variation. Results of four assays (1 ,2 , 3 ,4 ) preformed in four different days are shown.
ELISA OD from individual wells
Test 39 fluke 36 Fluke 26 Fluke
A B C mean A B C mean A B C mean
1 .232 .349 .356 .343 .329 .339 .311 .340 .347 .356 .259 .338
2 .436 .418 .429 .428 .394 .418 .422 .411 .364 .419 .402 .395
3 .378 .343 .369 .363 .370 .407 .416 .398 .362 .377 .386 .375
4 .386 .379 .402 .389 .375 .391 .362 .376 .362 .368 .331 .354
ELISA OD from individual wells (cont’d)
Test 26 fluke 22 fluke 0 fluke
A B C mean A B C mean A B C mean
1 .346 .346 .270 .275 .255 .294 .279 .275 .98 .94 .89 .94
2 .354 .401 .395 .383 .294 .380 .406 .360 .116 .98 .129 .112
3 .374 .354 .362 .363 .297 .376 .283 .319 .105 .95 .91 .97
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Fig. 4.3. Detection of purified coproantigen diluted in fecal supernatant from 
an uninfected calf: (■) purified coproantigen, (o) fecal supernatant from 
uninfected animals.
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all five animals at 6 weeks post-infection. Maximum coproantigen levels occurred 8 weeks 
after infection. The coproantigen level remained constant until the end o f the experiment 
(Fig. 4.4). No eggs were detected in the feces of the experimentally infected animals at week 
6 and eggs were detected in the feces of only two of the animals 8 weeks (data not shown). 
Relationship of coproantigen level, number of flukes and egg count:
Using the current procedure for determining fecal egg counts per 2 grams of feces, 
the egg counts for all the experimentally infected animals was low and detection of infection 
with less than 16 flukes was difficult. Of the 12 animals infected with less than 16 flukes 
only two had egg counts of 1 egg/2 gm of feces and the rest were negative. To increase the 
sensitivity o f egg detection, 6 grams of feces were used in the sedimentation procedure and 
the egg counts ranged from 0-11  with a slight positive correlation with the number of flukes 
( r = 0.39). Capture ELISA results on the same fecal samples showed a strong correlation 
( r =0.96) between the OD values of the fecal ELISA and number of flukes (Fig 4.5). There 
were also a slight correlation between the coproantigen and the egg count (r =0.36; data 
not shown).
DISCUSSION
Definitive diagnosis of fasciolosis is usually achieved by the detection o f eggs in the feces; 
however, this procedure is unable to predict the number of worms since the egg counts are 
variable and commonly less than 5 eggs per gram even in heavily infected herd. Moreover, 
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Fig. 4.4. Kinetics of coproantigen appearance in feces of experimentally infecietl calves with (h) 39 flukes, 
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Fig. 4. 5. Correlation of the OD values o f the capture ELISA and the egg per 
2 gram o f feces with the number o f flukes. Panel (A) capture ELISA (r= 0.96) 
and panel (B) fecal egg count (r= 0.39); ( • )  Positive feces, (o) negative feces 
and (■) number o f eggs.
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In addition, F. hepatica eggs may be confused with other trematode eggs from parasites such 
as Cotylophoron sp. and Paramphistomum spp. Therefore immunodiagnostic assays may 
be superior for diagnosis of fasciolosis.
In this study, using a capture ELISA, I evaluated Fasciola infection in the 
experimentally-infected calves by detection of coproantigen. The sensitivity of the capture 
ELISA for the detection o f infection with one or more flukes was 67% . I found that the 
ability o f the test to detect coproantigen was correlated with the fluke burden (Fig 4.2). 
The highest absorbance values occuned with calves infected with 39-28 fluke and the absorbance 
decreased to median level for those calves infected with 26-20 and a low but detectable 
absorbance value was seen in animals infected with 18-10 flukes. The test could not differentiate 
between those animals infected with less than 8 flukes (n=10) and the uninfected animals. 
Samples from the animals with less than 10 flukes were combined with the negative samples 
(n=17) and these were the negative control used to determine the sensitivity o f the test for 
detection o f infections with 10 flukes or more. The sensitivity of detection o f 10 flukes or 
more was 100% with specificity of 96.3%.
I previously localized the 26-28 kD coproantigen that binds to the MAb F10 to the 
tegumental cell and in the gut lining of the bile duct stages flukes (Chapter III). In the present 
study, the coproantigen was detected by the 6th week after infection. This coincides with 
the arrival o f the majority of the flukes in the bile duct (Soulsby, 1968) and when secretory 
and excretory products would be secreted into the bile. These results are similar to those 
obtained by WB (Chapter II). Samples prior to 6 weeks post-infection were not available,
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therefore I do not know if the antigen is detectable before 6 weeks. Based on previous reports, 
I believe that the antigen would not be detectable prior to 6 weeks since the flukes are outside 
tire bile ducts, thus the antigens would not be shed into the feces but would probably be present 
in the circulation. Maximum detection of the coproantigen occurred at 8 weeks post-infection. 
This could be attributed to the rapid growth and maturation o f the flukes which would be 
associated with a higher metabolic rate and increased shedding of the glycocalyx. I observed 
a very slight decrease in the absorbance values at 10 week after infection after which the 
level of coproantigen remained stable until the 13 week post-infection, when the experiment 
was terminated. My results complement those obtained by Langley and Hillyer (1989b) 
and by Rodriguez- Perez and Hillyer (1995). In their studies they observed a marked decrease 
in the level of the circulating immunecomplex and the circulating antigen by week 10 post­
infection, which they attributed to the establishment of the parasite in the bile duct and the 
availability of relatively less antigen in the circulation. Therefore, when the antigen decreases 
in the circulation after establishment of the fluke in the bile duct, it becomes detectable in 
the feces. After establishment in the bile duct there is continuous shedding o f the surface 
antigens but at a slightly slower rate (Hanna et al., 1980b) This slower rate o f shedding is 
reflected by the slight decrease in the absorbance value at 10 weeks post-infection. This 
is an advantage o f the capture ELISA for coproantigen over other immunoassays.
I determined that the capture ELISA for coproantigen was sensitive enough to detect 
300 pg coproantigen/ ml of fecal supernatant. This is 80-fold more sensitive than the ELISA 
for circulating antigen (25 ng/ml) reported by Langley and Hillyer (1989a) and 50-fold more
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sensitive than the 15 ng/ml that reported by the reported by Espino et al. ( 1994). The high 
sensitivity of this assay facilitates detection of low fluke burdens where the antigen is highly 
diluted in large amount of ingesta, as in the case o f cattle.
Malone and Craig (1990), reported that yearling calves infected with less than 20 
flukes shed an average of 1-5 eggs per 2 gram feces, those infected with 30 flukes shed an 
average o f 5-10 eggs and those who infected with 60 fluke shed an average o f 10-40 eggs 
per two grams of feces. In this study I could not detect eggs in 2 grams of feces from infected 
calves at 6 or 8 weeks after infection. At 10 weeks eggs were detected in only 2 animals 
infected with less than 13 flukes . When 6 gm of feces were used in the sedimentation 
procedure to increase the sensitivity of egg detection, I found two of the animals were shedding 
eggs 8 weeks post-infection. The correlation between the fluke burden and the egg count 
(r = 0.39) was low compared to the strong correlation between the coproantigen and the number 
o f flukes (r = 0.96). Duwel and Reisenleiter (1990) monitored egg shedding in bulls 
experimentally infected with different numbers of F. hepatica metacercaria and found that 
Fasciola egg counts fluctuated within one animal and within one infection group. He also 
found that the distribution of Fasciola eggs in the feces is irregular within one day and also 
over several days in all animals. In contrast, coproantigen detection is relatively stable as 
long as the flukes are in the bile duct.
Capture ELISA for coproantigen provides a sensitive, specific and rapid procedure 
for diagnosis o f fasciolosis. The assay correlated well with the number o f flukes making 
it possible to estimate fluke burden. I was able to detect early infection, that is before the
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adults mature and start to shed eggs. In addition, the capture ELISA has distinct advantages 
over other assays: 1) it only detects the antigen as long as the parasite is present in the bile 
duct, and 2) the simplicity of the sample collection, 3) Potential use of coproantigen detection 
for other mammalian tests o f F. hepatica, including human infections .
CHAPTER V
CONCLUSIONS
The presence of parasite specific antigens in the feces of infected hosts has recently 
received considerable attention as a means of diagnosis of a number o f parasites. The ultimate 
goal of this work was to develop a rapid, sensitive and specific test for detection of Fasciola 
hepatica coproantigen using MAbs. The specific aims were: 1) to detemiine the sensitivity 
and the specificity of the available 4 MAbs to the 26-28 kD antigen present in the feces of 
infected cattle using WB, 2) to characterize the antigen containing the epitope recognized 
by these MAbs; 3) to localize the coproantigen on the bile duct stages o f liver flukes and 
4) to develop a capture ELISA for detection o f the coproantigen.
My first aim was determine the specificity and the sensitivity of the available MAbs 
to the coproantigen. Western blot analysis was used to detect the presence of coproantigen 
in feces of experimentally infected calves. Using WB and the colorimetric substrate TMB, 
culture supernatant containing the 4 MAbs were shown to react with a 26-28 kD band of 
the excretory secretory product (ES) but the MAbs were not concentrated enough to reveal 
the band in the feces. However, the band was detected in the feces using ECL substrate which 
indicated that ECL is more sensitive substrate than TMB. By using purified MAbs at 10 
pg/ml, the 26-28 kD coproantigen could be detected in the feces o f infected animals. To 
further enhance the detection, a biotin-streptavidin modification was employed and was found 
to increase the sensitivity. I found that the most sensitive detection of the coproantigen by
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WB (>10 flukes) was achieved using the biotin-streptavidin modification and TMB substrate. 
To determine the specificity of the MAbs for F. hepatica, the MAbs were then tested against 
fresh fluke antigen (FAA) and ES of other trematode and cestode parasites that commonly 
occur in cattle or that are related to F. hepatica. For example, Paramphistomum spp. eggs 
are sometimes confused with F. hepatica eggs in routine fecal sedimentation examinations. 
Using WB, I found that the MAbs do not recognize antigens in the ES of P. microbothriodes, 
an advantage o f the test. There was also no cross-reactivity with the cestode parasite Moniezia 
sp. However, minimum cross-reactivity was observed with ES o f F. gigantica, which is 
found in tropical and subtropical regions of the world and therefore would not be a problem 
with samples in North America. The MAbs also cross-reacted with the ES of Fascioloides 
magna, a deer liver fluke that sometimes incidentally infects cattle in ranges shared with 
deer. However, cattle are an abnormal host, and encapsulation of F. magna typically prevents 
shedding of eggs into the feces. Further investigation is needed to determine if the F. magna 
antigens are excreted in the feces of infected animals and whether these antigens can be detected 
in the feces by these MAbs.
The second aim of this study was to characterize the nature of this antigen. The 26-28 
kD antigen was purified from ES by gel filtration. The purified 26-28 kD antigen was 
unchanged under reducing and non-reducing conditions. The pattern of staining of the 26-28 
kD coproantigen with differential stains suggested that the molecule is a proteoglycan. Alkaline 
treatment of the purified coproantigen resulted in the disappearance o f the 26-28 kD band 
and generation o f a new band o f 8 kD that was recognized by the MAbs in WB.
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Endoglycosidase F or endoglycosidase H had no effect on the coproantigen. Together, 
these results indicated that the coproantigen is a monomeric proteoglycan o f which 70% 
of its mass is a carbohydrate and is probably O-glycosylated. Further, the specific epitope 
recognized by the MAbs is on the protein core, not in the carbohydrate component. Potential 
protease activity o f the coproantigen, as determined by gelatin SDS-PAGE, indicated that 
the coproantigen is not a protease.
In transit from the bile ducts through the intestinal tract, the coproantigen is exposed 
to digestive enzymes such as pepsin (found in the gastric juice) and trypsin (found in the 
small intestinal digestive fluid) and is therefore exposed to the effect o f these proteases. 
The antigenicity of the coproantigen was not affected by the treatment by pepsin, but treatment 
with trypsin resulted in the generation o f an 18 kD molecule which retained the epitope 
recognized by the MAbs used in this study. Studies on the effect o f the different storage 
temperatures on the coproantigen revealed that although there are shifts in the band size due 
to an apparent gradual loss of glycosylation or proteolytic cleavage, the antigenicity was 
retained.
The third specific aim was to localize the antigen on the flukes. Three o f the MAbs 
(F10, G7 and E7) were found to recognize an antigen in the tegument and the gut of the adult 
worm. The fourth MAb (F7), recognized antigen only in the gut of the fluke. The resultswere 
identical for immature bile duct flukes.
The fourth specific aim was to develop a sensitive, rapid and easy test for diagnosis 
of fasciolosis. I developed a capture ELISA to detect the coproantigen in calves experimentally-
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infected with F. hepatica. The assay was able to detect Fasciola in animals infected with 
more than 10 flukes. I found that the ability o f the test to detect coproantigen was positively 
correlated with the fluke burden (r = 0.96) and that the test was able to detect as little as 300 
pg o f coproantigen per ml of fecal supernatant. Detectable level o f coproantigen was present 
in all five animals at 6 weeks post-infection and that maximal coproantigen levels occurred 
8 weeks post-infection. However, no eggs were detected in the feces of the experimentally 
infected animals at week 6 and only two of the had animals started egg shedding at 8 week. 
Together, these data indicate that this capture ELISA for the F. hepatica 26-28 kD coproantigen 
is a more sensitive and quantitative assay than fecal egg counts. In addition, the assay is 
rapid, easy to perform and lends itself well to large numbers o f samples. The test may be 
useful for detecting infections on other hosts, including zoonotic human infections. The assay 
can detect infection as early as 6 weeks post-infection, before flukes are sexually mature 
and producing eggs.
Future studies:
Future studies will concentrate on field evaluation of the sensitivity and the specificity 
of this test on cattle naturally infected with F. hepatica. Since the earliest time point in my 
study was 6 weeks post infection, additional experimental-infections are needed to determine 
how soon after infection the coproantigen can be detected. These studies could also address 
the possibility that the 26-28 kD antigen may be present in the circulation prior to the arrival 
of the flukes in the bile duct.
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Capture ELISA may also be useful in the detection o f human fasciolosis. Since this 
capture ELISA is very sensitive and since human feces are not as diluted as the feces of cattle, 
it might be possible to detect a single worm infection in human patients using the capture 
ELISA. The possible cross-reactivity with other human parasites should also be examined.
The potential usefulness o f the coproantigen as a vaccine could be tested by 
immunization o f rats with the chromatographically purified 26-28 kD antigen followed by 
challenge with F. hepatica metacercarae. If the 26-28 kD antigen was protective, the protein 
could be sequenced. DNA primers deduced from the protein sequence would allow the gene 
to be identified. This would supply additional information on the biology of the coproantigen 
as well as act as a step toward the development of a recombinant vaccine against F. hepatica 
infection.
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